Camtek (CAMT) 20-F 4 Mar 14 2013 FY Annual report (foreign) Financial data

Document_and_Entity_Informatio

Document and Entity Information	12 Months Ended
	Dec. 31, 2013
Document And Entity [Abstract]	'
Document Type	'20-F
Amendment Flag	'false
Document Period End Date	31-Dec-13
Entity Registrant Name	'CAMTEK LTD
Entity Central Index Key	'0001109138
Current Fiscal Year End Date	'--12-31
Document Fiscal Period Focus	'FY
Document Fiscal Year Focus	'2013
Entity Filer Category	'Non-accelerated Filer
Entity Common Stock, Shares Outstanding	29,896,933
Entity Well-known Seasoned Issuer	'No
Entity Voluntary Filers	'No
Entity Current Reporting Status	'Yes

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets	'		'
Cash and cash equivalents	$16,495		$18,867
Short-term deposits	6,000		7,160
Trade accounts receivable, net	27,048		23,076
Inventories	17,911		18,335
Due from affiliated companies	233		391
Other current assets	1,913		2,210
Deferred tax asset	938		367
Total current assets	70,538		70,406
Property, plant and equipment, net	14,481		15,822
Long-term inventory	2,225	[1]	7,090
Long-term restricted deposit	729		729
Deferred tax asset	975		107
Other assets	339		304
Intangible assets, net	1,008		2,971
Goodwill	1,555		1,579
Total noncurrent assets	6,831		12,780
Total assets	91,850		99,008
Current liabilities	'		'
Short-term loan	'		4,160
Trade accounts payable	7,753		7,610
Current installments of long-term bank loans	'		1,592
Other current liabilities	15,585		13,850
Total current liabilities	23,338		27,212
Long-term liabilities	'		'
Long-term bank loans	'		500
Liability for employee severance benefits	858		710
Other long-term liabilities	5,758		10,249
Total noncurrent liabilities	6,616		11,459
Total liabilities	29,954		38,671
Commitments and contingencies	'		'
Shareholders' equity	'		'
Ordinary shares NIS 0.01 par value, authorized 100,000,000 shares, issued 32,497,902 as of December 31, 2013 and 31,989,309 as of December 31, 2012, outstanding 30,405,526 as of December 31, 2013 and 29,896,933 as of December 31, 2012	134		133
Additional paid-in capital	62,966		61,415
Retained earnings	694		687
Total shareholders' equity before treasury stock	63,794		62,235
Treasury stock, at cost (2,092,376 as of December 31,2013 and 2012)	-1,898		-1,898
Total shareholders' equity	61,896		60,337
Total liabilities and shareholders' equity	$91,850		$99,008
[1]	Long-term Inventory: At December 31, 2013, $2,225 of the Company's inventory is classified in long-term assets based on Management's estimate and the recent level of sales (at December 31, 2012- $7,090). Of this amount, $1,353 is comprised of spare parts (at December 31, 2012 - $2,193). The Company's policy is to keep components to provide support and service to systems sold by it to its customers over the past years (usually the support is over a period of seven to ten years) until the Company announces it will not continue to support certain systems. Therefore, this inventory is usually consumed over longer periods than inventory held for sale, and as such the respective amount that is not expected to be consumed in the next year is classified as non-current. Management believes that this amount will be utilized according to its forecasted sales. Management believes no loss will be incurred on its disposition. The remaining portion of long-term inventory consists of DMD components and systems which in Management's estimation will not be sold during the next 12 months. Management believes that according to its forecasted sales this amount will mainly be utilized in 2015. Management believes no loss will be incurred on its disposition.

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (ILS)	Dec. 31, 2013	Dec. 31, 2012
Consolidated Balance Sheets [Abstract]	'	'
Common Stock, par value per share	0.01	0.01
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	32,497,902	31,989,309
Common Stock, shares outstanding	30,405,526	29,896,933
Treasury Stock, shares	2,092,376	2,092,376

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues:	'	'	'
Sales of products	$67,864	$66,929	$88,404
Service fees	17,541	17,618	18,624
Total revenues	85,405	84,547	107,028
Cost of revenues:	'	'	'
Cost of products sold	38,692	35,908	48,039
Cost of services	12,311	11,574	11,549
Total cost of revenues	51,003	47,482	59,588
Gross profit	34,402	37,065	47,440
Research and development costs	14,370	12,916	14,077
Selling, general and administrative expenses	22,362	21,138	24,341
Reorganization and impairment	-3,466	3,031	'
Total operating expenses	33,266	37,085	38,418
Operating income (loss)	1,136	-20	9,022
Financial income (expenses), net	-1,738	233	-2,900
Income (loss) before income taxes	-602	213	6,122
Income tax (expense)	609	-210	-744
Net income	$7	$3	$5,378
Earnings per ordinary share:	'	'	'
Basic	$0	$0	$0.18
Diluted	$0	$0	$0.18
Weighted average number of ordinary shares outstanding:	'	'	'
Basic	30,040	29,849	29,557
Diluted	30,094	30,013	30,009

Consolidated_Statements_of_Sha

Consolidated Statements of Shareholders' Equity (USD $)	Total	Ordinary Shares NIS 0.01 par value [Member]		Treasury stock [Member]	Additional paid-in capital [Member]		Retained earnings (accumulated losses) [Member]
In Thousands, except Share data
Balance, value at Dec. 31, 2010	$53,992	$132		($1,898)	$60,452		($4,694)
Balance, shares at Dec. 31, 2010	'	31,370,359		-2,092,376	'		'
Exercise of share options and RSUs, value	146	1		'	145		'
Exercise of share options and RSUs, shares	'	439,981		'	'		'
Share based compensation expense	417	'		'	417		'
Net income	5,378	'		'	'		5,378
Balance, value at Dec. 31, 2011	59,933	133		-1,898	61,014		684
Balance, shares at Dec. 31, 2011	'	31,810,340		-2,092,376	'		'
Exercise of share options and RSUs, value	'	'	[1]	'	'	[1]	'
Exercise of share options and RSUs, shares	'	178,969		'	'		'
Share based compensation expense	401	'		'	401		'
Net income	3	'		'	'		3
Balance, value at Dec. 31, 2012	60,337	133		-1,898	61,415		687
Balance, shares at Dec. 31, 2012	29,896,933	31,989,309		-2,092,376	'		'
Exercise of share options and RSUs, value	1,172	1		'	1,171		'
Exercise of share options and RSUs, shares	'	508,593		'	'		'
Share based compensation expense	380	'		'	380		'
Net income	7	'		'	'		7
Balance, value at Dec. 31, 2013	$61,896	$134		($1,898)	$62,966		$694
Balance, shares at Dec. 31, 2013	30,405,526	32,497,902		-2,092,376	'		'
[1]	Less than $ 1 thousand

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:	'	'	'
Net income	$7	$3	$5,378
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Depreciation and amortization	2,587	2,125	2,366
Loss on disposal of fixed assets	867	'	'
Impairment losses	1,708	3,031	'
Accrued interest on restricted deposit	'	'	7
Deferred tax benefit	-1,439	-232	-36
Share based compensation expense	380	401	417
Provision for bad debts, net	54	167	-2
Revaluation of contingent liabilities and interest expense on liabilities to the OCS	-3,701	-586	1,997
Changes in operating assets and liabilities:	'	'	'
Trade accounts receivable, net	-3,827	2,270	3,451
Inventories	5,454	34	-318
Due from affiliated companies	158	-3	-4
Other assets	262	1,147	-787
Trade accounts payable	143	837	-2,988
Other current liabilities	1,852	-5,302	290
Liability for employee severance benefits	148	58	26
Net cash provided by operating activities	4,653	3,950	9,797
Cash flows from investing activities:	'	'	'
Restricted deposit	'	'	5,175
Investment in long-term deposit	'	-729	'
Payment of (investment in) short-term deposits	1,160	-3,060	-4,100
Purchase of fixed assets	-1,857	-2,035	-1,064
Purchase of intangible assets	-142	-222	-483
Net cash used in investing activities	-839	-6,046	-472
Cash flows from financing activities:	'	'	'
Increase in bank loans	'	4,160	6,200
Repayment of contingent liability	-640	-331	-421
Payment to OCS	-267	-289	-609
Repayment of loans	-6,252	-4,700	-1,950
Proceeds from exercise of share options and RSUs	1,172	'	146
Net cash (used in) provided by financing activities	-5,987	-1,160	3,366
Effect of exchange rate changes on cash	-199	-62	-83
Net (decrease) increase in cash and cash equivalents	-2,372	-3,318	12,608
Cash and cash equivalents at beginning of the year	18,867	22,185	9,577
Cash and cash equivalents at end of the year	16,495	18,867	22,185
Supplementary cash flows information:	'	'	'
Cash paid during the year for interest	131	137	157
Cash paid during the year for income taxes	$250	$348	$495

Nature_of_Operations

Nature of Operations	12 Months Ended
	Dec. 31, 2013
Nature of Operations [Abstract]	'
Nature of Operations	'
	Note 1 - Nature of Operations
		A.	Camtek Ltd. ("Camtek"), an Israeli corporation, is a majority owned (55.65%) subsidiary of Priortech Ltd. ("Parent"), an Israeli corporation listed on the Tel-Aviv Stock Exchange. Camtek designs, develops, manufactures and markets automatic optical inspection systems ("AOI systems") and related products. Camtek's AOI systems are used for yield enhancement for various applications in the electronic supply chain industry. The main applications along this supply chain are the production of microelectronics, printed circuit boards (PCB) and electronic packaging.
	All of Camtek's activities are conducted in one reportable business segment.
		B.	In December 2013, Camtek decided not to continue with the development of future models of its Xact product line which had been acquired as part of the SELA acquisition. Camtek intends to sell existing inventory of other Sela products and will continue to support the Sela customer base. Accordingly, Camtek wrote off excess inventories, fixed assets, related intangible assets, goodwill and adjusted its liabilities in respect to the SELA acquisition.
		The impact of this decision on the consolidated statement of income was as follows:
				Year ended
				December 31,
				2013
				U.S. Dollars in
	Account		Nature of impact	millions
	Cost of Revenues		Inventory write-off		3.1
	Reorganization and impairment		Impairment charge with respect of technology, customer relationships and goodwill		1.7
	Reorganization and impairment		Revaluation of liabilities in respect of SELA acquisition		(5.1	)
	Relevant areas in consolidated statement of income		Other (mainly due to disposal of fixed assets)		0.8
					0.5

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Significant Accounting Policies [Abstract]	'
Significant Accounting Policies	'
	Note 2 - Significant Accounting Policies
	A.           Basis of preparation of the financial statements
	The consolidated financial statements of Camtek and its subsidiaries (collectively "the Company") have been prepared in accordance with accounting principles generally accepted in United States of America ("US GAAP").  All amounts in the notes to the financial statements are in thousands unless otherwise stated.
		B.	Principles of consolidation
	The accompanying consolidated financial statements include the accounts of Camtek and its subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.
		C.	Use of estimates
	The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. As applicable to these financial statements, the most significant estimates and assumptions relate to revenue recognition, valuation of accounts receivable, inventories, intangible assets and goodwill, other long-lived assets, deferred tax assets, legal contingencies, contingent consideration and share based compensation among others. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. It is often difficult to accurately estimate the ultimate outcome of a contingent liability. Different variables can affect the timing and amount that management provides for certain contingent liabilities. The Company's assessments are therefore subject to estimates made by management and its legal counsel. Adverse revision in management estimates of the potential liability could materially impact the Company's financial condition, results of operations or liquidity.
	The Company adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.
		D.	Foreign currency transactions
	The functional currency of the Company and its subsidiaries is the U.S. Dollar. Revenue generated by the Company and its subsidiaries is primarily generated outside of Israel and a majority thereof is received in U.S. Dollars. In addition, materials and components purchased and marketing expenses incurred are either paid for in U.S. Dollars or in New Israeli Shekels ("NIS") linked to changes in the U.S. Dollar/NIS exchange rate.
	Transactions not denominated in U.S. Dollars are recorded upon their initial recognition according to the exchange rate in effect on the date of the transaction. Exchange rate differences arising upon the settlement of monetary items or upon reporting the Company's monetary items at exchange rates different from that by which they were initially recorded during the period, or reported in previous financial statements, are charged to financial income (expenses), net.
		E.	Cash and cash equivalents
	All highly liquid investments purchased with original maturities of three months or less are considered to be cash equivalents.
		F.	Trade accounts receivable and allowance for doubtful accounts
	Accounts receivable are recorded at the outstanding recognized amount and do not bear interest. The allowance for doubtful accounts represents Management's best estimate of the probable loss inherent in existing accounts receivable balances as a result of possible non-collection. In determining the appropriate allowance, Management bases its estimate on information available about specific debtors, including aging of the balance, assessment of the underlying security received, the history of write-offs, relationships with the customers and the overall creditworthiness of the customers.
		G.	Inventories
	Inventories consist of completed systems, partially completed systems and components and other raw materials, and are recorded at the lower of cost or market. Cost is determined by the moving - average cost method basis.
	Inventory write-downs are recorded at the end of each fiscal period for damaged, obsolete, excess and slow-moving inventory. These write-downs, to the lower of cost or market value, create a new cost basis that is not subsequently marked up based on changes in underlying facts and circumstances.
	Management periodically evaluates its inventory composition, giving consideration to factors such as the probability and timing of anticipated usage and the physical condition of the items, and then estimates a charge (reducing the inventory) to be provided for slow moving, technological obsolete or damaged inventory. These estimates could vary significantly, from actual requirements based upon future economic conditions, customer inventory levels or competitive factors that were not foreseen or did not exist when the inventory write-downs were established.
	Inventory that is not expected to be converted or consumed within the next year is classified as non-current, based on Management's estimates taking into account market conditions.
		H.	Property, plant and equipment
	These assets are stated at cost less accumulated depreciation, and are depreciated over their estimated useful lives on a straight-line basis.
	Annual rates of depreciation are as follows:
	Building			2	%
	Machinery and equipment			10% - 33	%
	Computer equipment and software			20%-33	%
	Office furniture and equipment			6% - 20	%
	Automobiles			15	%
	Leasehold improvements are amortized by the straight-line method over the shorter of the lease term or the estimated useful economic life of such improvements.
	Certain of the Company's finished goods are systems used as demonstration systems, training systems, and for product development in the Company's laboratories ("internal use"). These systems are identical to the systems that Camtek sells in its ordinary course of business. In circumstances where the Company intends to utilize such systems for its internal use, the Company transfers them from inventory to fixed assets. The rationale for the transfer is that the Company does not have the intention to sell these systems in the ordinary course of business but rather expects to use them for its internal use over their expected useful lives. These systems are recorded as fixed assets at cost and depreciated over their useful lives.
		I.	Intangible assets
	Patent registration costs are recorded at cost and amortized, beginning with the first year of utilization, over its expected useful life.
	Intangible assets purchased as part of the business combinations were recorded at their fair value and are amortized based on their remaining estimated useful lives. Acquired in-process research and development (IPR&D) will be amortized starting at the initial date of recording revenues from the associated technology.
		J.	Goodwill
	Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at least annually in accordance with the provisions of FASB ASC Topic 350, Intangibles - Goodwill and Other. The goodwill impairment test is a two ­step test. Under step one, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the entity must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit's goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to an acquisition price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed.
	The Company has set its annual impairment testing date at December 31. As of December 31, 2013 and 2012, based on the Company's annual impairment test, impairment charges were recognized. (See Note 9).
		K.	Impairment of long-lived assets
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of the long lived asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized to the extent that the asset's carrying amount exceeds its fair value (See Note 9).
		L.	Fair values of financial instruments
	The carrying amounts of the Company's financial instruments, including cash and cash equivalents, short-term deposits, trade accounts receivable, trade accounts payable, short-term liabilities to banks and amounts from affiliates approximate fair value because of their short-term maturities.
	The fair value of the long-term restricted deposit approximates the carrying amount, since it bears floating rate interest at the market rate.
	The fair value of long-term liabilities to banks also approximate the carrying amounts, since they bear floating rate interest at rates close to prevailing market rates.
	The contingent consideration liabilities relating to the Company's business combinations are measured at fair value at each balance sheet date.
		M.	Revenue recognition
	The Company recognizes revenue from sales of its products when the products are installed at the customer's premises and are operating in accordance with its specifications, signed documentation of the arrangement, such as a signed contract or purchase order, has been received, the price is fixed or determinable and collectibility is reasonably assured.
	In the limited circumstances when the products are installed by a trained distributor acting as an end user, revenue is recognized upon delivery to the distributor assuming all other criteria for revenue recognition are met.
	Service revenues consist mainly of revenues from maintenance contracts and are recognized ratably over the contract period.
	The Company implements the provisions of ASU 2009-13, Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements, and therefore for multiple-element arrangements the overall arrangement fee is allocated to each element (both delivered and undelivered elements) based on management's best estimate of their selling price where other sources of evidence are unavailable. The revenue relating to the undelivered elements is deferred using the relative selling price method utilizing vendor-specific-objective evidence ("VSOE") until delivery of the deferred elements.
	The Company's multiple deliverable arrangements consist of product sales and non-standard warranties. A non-standard warranty is one that is for a period longer than 12 months. Accordingly, income from a non-standard warranty is deferred as unearned revenue and is recognized ratably as revenue commencing with and over the applicable warranty term.
	The Company routinely evaluates its products for inclusion of any embedded software that is more than incidental thereby requiring consideration of ASC Subtopic 985-605, "Software Revenue Recognition".  Based on such evaluation, the Company has concluded that none of its products have such embedded software.
	N.           Warranty
	The Company records a liability for standard product warranty obligations at the time of sale based upon historical warranty experience. The term of the warranty is generally twelve months.
	For the Company's treatment of non-standard warranties, see Note 2(M) - Revenue recognition.
	O.           Income taxes
	The Company accounts for income taxes in accordance with the asset and liability method whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. However, the Company does not recognize deferred taxes for differences related to assets and liabilities that are remeasured from the local currency into the functional currency using historical exchange rates and that result from changes in exchange rates or indexing for tax purposes. The Company presents foreign currency transaction gains and losses from remeasuring income tax assets and liabilities with income tax (benefit) expense. The Company provides a valuation allowance to reduce deferred tax assets to the amount that is more likely than not to be realized.
	The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is more than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.
	P.           Research and development
	Research and development costs are expensed as incurred.
	Q.           Earnings / loss per ordinary share
	Basic earnings/loss per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year.  Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options, warrants and convertible loan.
	For the years ended December 31, 2013, 2012 and 2011, the effect of the exercise of outstanding dilutive potential share options and Restricted Share Units ("RSUs") has been included in computing dilutive earnings per ordinary share (see Note 18).
	R.           Share-based compensation
	The Company accounts for its employee share-based compensation as an expense in the financial statements. All awards are equity classified and therefore such cost is measured at the grant date fair value of the award. The Company estimates share option grant date fair value using the Black-Scholes-Merton option-pricing model. (For details see Note 17).
	S.	Fair value measurements
The Company implements the provisions of ASC Topic 820 "Fair Value Measurements and Disclosures" ("ASC 820"). ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3 inputs are unobservable inputs for the asset or liability. (For details see Note 23).
	T.	Derivative instruments
The Company enters into option contracts and forward exchange agreements in order to reduce its exposure with respect to various commitments in currencies other than the dollar, in connection with expenses in New Israeli Shekels.
The Company does not issue or hold derivative financial instruments for trading purposes, but rather to manage its foreign currency exposure.  Nevertheless, these transactions do not meet all the conditions for hedge accounting and accordingly, the changes in fair value of such instruments are recorded directly to financial income (expenses), net.
The Company's foreign exchange derivative contracts are marked-to-market based on the determined fair value of open contracts at period end. (See Note 16).
	U.	Contingent liabilities
A contingency (provision) in accordance with ASC Topic 450-10-05, Contingencies, is an existing condition or situation involving uncertainty as to the range of possible loss to the entity.
A provision for claims is recognized if it is probable (likely to occur) that a liability has been incurred and the amount can be estimated reasonably.
	V.	Government-sponsored research and development
The Company records grants received from the Office of the Chief Scientist of the Israeli Ministry of Industry and Trade (the "OCS") as a liability, if it is probable that the Company will have to repay the grants received. If it is not probable that the grants will be repaid, the Company records the grants as a reduction to research and development expenses. Royalties paid to the OCS are recognized as a reduction of the above liability.
The Company accounts for OCS liabilities acquired in business combinations within the confines of debt obligations and as such changes in the liability from period to period, caused by changes to the estimated timing of future repayments and accrued interest, are accounted for prospectively and recorded as financial expenses (income). (See Note 14 and Note 15F).
	W.	Recently issued and adopted accounting standards
In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. ASU 2013-11 requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. ASU 2013-11 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The new standard is to be applied prospectively but retrospective application is permitted.  The Company will implement the provisions of ASU 2013-11 as of January 1, 2014.

Cash_and_Cash_Equivalents

Cash and Cash Equivalents	12 Months Ended
	Dec. 31, 2013
Cash and Cash Equivalents [Abstract]	'
Cash and Cash Equivalents	'
	Note 3 - Cash and Cash Equivalents
		December 31,
		2013		2012
		U.S. Dollars
	Bank balances		16,405		13,790
	Call deposits		-		4,987
	Restricted cash		90		90
			16,495		18,867
	As of December 31, 2013 and 2012, $90 were restricted against credit lines to banking institutions in Hong Kong (denominated in Hong Kong Dollars).
	The Company's cash and cash equivalent balance at December 31, 2013 and 2012 is denominated in the following currencies:
		December 31,
		2013		2012
		U.S. Dollars
	US Dollars		11,015		13,933
	Euro		1,936		1,476
	New Israeli Shekels		1,208		1,742
	Chinese RMB		1,101		1,149
	Other currencies		1,235		567
			16,495		18,867

Inventories

Inventories	12 Months Ended
	Dec. 31, 2013
Inventories [Abstract]	'
Inventories	'
	Note 4 - Inventories
			December 31,
			2013		2012
			U.S. Dollars
	Components			11,115		12,313
	Work in process			3,795		6,658
	Finished products (including systems at customer locations not yet sold)			5,226		6,454
				20,136		25,425
	Inventories are presented in:
			December 31,		December 31,
			2013		2012
			U.S. Dollars
	Current assets			17,911		18,335
	Long-term assets (A)			2,225		7,090
				20,136		25,425
	(A)          Long-term Inventory:
	At December 31, 2013, $2,225 of the Company's inventory is classified in long-term assets based on Management's estimate and the recent level of sales (at December 31, 2012- $7,090). Of this amount, $1,353 is comprised of spare parts (at December 31, 2012 - $2,193). The Company's policy is to keep components to provide support and service to systems sold by it to its customers over the past years (usually the support is over a period of seven to ten years) until the Company announces it will not continue to support certain systems. Therefore, this inventory is usually consumed over longer periods than inventory held for sale, and as such the respective amount that is not expected to be consumed in the next year is classified as non-current. Management believes that this amount will be utilized according to its forecasted sales. Management believes no loss will be incurred on its disposition.
	The remaining portion of long-term inventory consists of DMD components and systems which in Management's estimation will not be sold during the next 12 months. Management believes that according to its forecasted sales this amount will mainly be utilized in 2015. Management believes no loss will be incurred on its disposition.
		(B)	As of December 31, 2013, based on the Company's decision in November 2013 not to continue with development of future models of its Xact product line, an obsolescence provision was recorded in the amount of $3,052 against SELA inventory (at December 31, 2012 - $1,420).
	The provision is recorded in the costs of products sold line item in the consolidated statement of operations. This provision results in a new cost basis that is not subsequently marked up based on changes in underlying facts and circumstances.
		(C)	In addition to the above mentioned in 4B, as of December 31, 2013, based on Management's estimates regarding future sales, a provision of $540 was made against damaged, obsolete, excess and slow-moving inventory (at December 31, 2012 - $406).

Other_Current_Assets

Other Current Assets	12 Months Ended
	Dec. 31, 2013
Other Current Assets [Abstract]	'
Other Current Assets	'
	Note 5 - Other Current Assets
		December 31,		December 31,
		2013		2012
		U.S. Dollars
	Due from Government institutions		424		501
	Prepaid expenses		454		427
	Advances to suppliers		290		340
	Deposits for operating leases		69		151
	Other		676		791
			1,913		2,210

Property_Plant_and_Equipment_N

Property, Plant and Equipment, Net	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment, Net [Abstract]	'
Property, Plant and Equipment, Net	'
	Note 6 - Property, Plant and Equipment, Net
		December 31,
		2013		2012
		U.S. Dollars
	Land		863		863
	Building		10,245		10,230
	Machinery and equipment		6,504		9,721
	Office furniture and equipment		1,202		997
	Computer equipment and software		4,566		5,683
	Automobiles		65		99
	Leasehold improvements		1,048		1,237
			24,493		28,830
	Less accumulated depreciation		10,012		13,008
			14,481		15,822
	Depreciation expenses for the years ended December 31, 2013, 2012 and 2011 amounted to $2,166, $1,640, and $1,911, respectively.
	In accordance with agreements signed in August 2010 and August 2011 with Bank Leumi L'Israel and in August 2011 with Bank Mizrahi, a lien has been placed on the Company's facility in Israel. See Note 15(D) and Note 15(E).

LongTerm_Restricted_Deposit

Long-Term Restricted Deposit	12 Months Ended
	Dec. 31, 2013
Long-Term Restricted Deposit [Abstract]	'
Long-Term Restricted Deposit	'
	Note 7 - Long-Term Restricted Deposit
	In October 2012, the Company was required to post an appeal bond of $729 with the United States District Court for the District of Minnesota ("the Court"), in order to stay collection of the judgment pending resolution of the appeal. The bond accrues interest at the US Treasury Bill daily rate. See Note 15(C).

Other_Assets

Other Assets	12 Months Ended
	Dec. 31, 2013
Other Assets [Abstract]	'
Other Assets	'
	Note 8 - Other Assets
		December 31,
		2013		2012
		U.S. Dollars
	Deposits for operating leases		339		304

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets, Net	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets, Net [Abstract]	'
Goodwill and Intangible Assets, Net	'
	Note 9 - Goodwill and Intangible Assets, Net
	A.           Goodwill
		December 31,
		2013			2012
		U.S. Dollars
	Goodwill		3,653			3,653
	Accumulated impairment losses		(2,098	)		(2,074	)
			1,555			1,579
	1.            Printar
	As of December 31, 2013, based on the Company's annual impairment test, no impairment charge was recognized for the goodwill recorded in the Printar acquisition.
	As of December 31, 2012, due to delays in the development activity of 3D Inkjet during 2012 and based on the Company's impairment test, the carrying amount was greater than the fair value of the reporting unit (as determined using the present value of future cash flows) and the carrying amount of the reporting unit's goodwill exceeded the implied value of that goodwill, resulting in an impairment charge of $575 in respect of the goodwill recorded in the Printar acquisition (see also Note 9B). The impairment charge was recorded in a separate line item within operating expenses in the consolidated statement of operations.
	2.            SELA
	During the fourth quarter of 2013, the Company announced that it will not continue with development of future models of its Xact product line. This resulted in an impairment of the Company's remaining goodwill with respect to SELA in the amount of $24 (at December 31, 2012 - $1,499). The impairment charge was recorded in a separate line item within operating expenses in the consolidated statement of operations.
	B.           Intangible assets, net
		December 31,
		2013			2012
		U.S. Dollars
	Patent registration costs		1,805			1,663
	IPR&D		1,002			1,002
	Technology		2,854			2,854
	Customer relationships		45			45
	Intangible assets at cost		5,706			5,564
	Accumulated amortization and impairment		4,698			2,593
	Total intangible asset, net		1,008			2,971
	Patent registration costs are amortized over their estimated useful life of 10 years. The IPR&D will be amortized over its estimated useful lives of 10.
	Amortization expense for the years ended December 31, 2013, 2012 and 2011 amounted to $421, $485 and $455, respectively. The amortization expense for 2013 includes the write-off of patents with a net value of $33 which were abandoned (in 2012 and 2011 - $28 and $24, respectively).
	In 2013, the Company recorded an impairment charge of $1,684 with respect to the technology and customer relationships based on the annual impairment test as determined using the present value of future cash flows (see also Note 9A). The impairment charge was recorded in a separate line item within operating expenses in the consolidated statement of operations (at December 31, 2012 - $957).
	As of December 31, 2013, the estimated amortization expenses of intangible assets for the years 2014 to 2018 is as follows:
	Year ending December 31,	U.S. Dollars
	2014		163
	2015		162
	2016		162
	2017		139
	2018		123
			749

Short_Term_Loan

Short Term Loan	12 Months Ended
	Dec. 31, 2013
Short Term Loan [Abstract]	'
Short Term Loan	'
	Note 10 - Short-Term Loan
	In 2012 the Company received various short-term loans totaling $4,160 from Bank Mizrahi and Bank Leumi L'Israel. The loans were each for up to twelve months and accrue interest in the range of Libor + 3% to Libor + 3.5%. During 2013, these loans were fully repaid ahead of original schedule.

Other_Current_Liabilities

Other Current Liabilities	12 Months Ended
	Dec. 31, 2013
Other Current Liabilities [Abstract]	'
Other Current Liabilities	'
	Note 11 - Other Current Liabilities
		December 31,
		2013			2012
		U.S. Dollars
	Accrued employee compensation and related benefits		6,546			5,478
	Accrued expenses		2,291			2,076
	Commissions		2,040			1,895
	Advances from customers and deferred revenues		1,985			1,843
	Accrued warranty costs		1,304			1,150
	Government institutions		992			864
	Current maturities of contingent consideration (1)		268			335
	Current maturities of OCS liability (1)		159			209
			15,585			13,850
	Changes in the accrued warranty costs are as follows:
		Year Ended December 31,
		2013			2012			2011
		U.S. Dollars
	Beginning of year		1,150			1,637			1,494
	New warranties		2,327			2,159			3,179
	Reductions		(2,173	)		(2,646	)		(3,036	)
	Balance at end of year		1,304			1,150			1,637
	(1)           See also Note 14 - Other long-term liabilities

Longterm_loans

Long-term loans	12 Months Ended
	Dec. 31, 2013
Long-term loans [Abstract]	'
Long-term loans	'
	Note 12 - Long-term loans
	During 2010 and 2011, the Company received long-term loans from Bank Leumi L'Israel in the total amount of $2,500. The long-term loans were subject to certain financial covenants described in Note 15(D).
	In August 2011, the Company received a long-term loan from Bank Mizrahi in the amount of $2,000. The long-term loan was subject to certain financial covenants. See also Note 15(E).
	In December 2013 the outstanding balance of the long-term loans was repaid ahead of the original schedule.

Liability_for_Employee_Severan

Liability for Employee Severance Benefits	12 Months Ended
	Dec. 31, 2013
Liability for Employee Severance Benefits [Abstract]	'
Liability for Employee Severance Benefits	'
	Note 13 - Liability for Employee Severance Benefits
	Under Israeli law and labor agreements the Company is required to pay severance payments to each employee who was employed by the Company for over one year and has been terminated by the Company or resigned under certain specified circumstances. The liability related to these severance payments is calculated on the basis of the latest salary of the employee multiplied by the number of years of employment as of the balance sheet date. The Company also has defined contribution plans for which it makes contributions to severance pay funds and appropriate insurance policies. Withdrawal of the reserve monies is contingent upon the fulfillment of detailed provision in the Severance Law.
	Under local law in various territories in which the Company operates, employees with one year or more of service are entitled to receive a lump-sum payment upon termination of their employment based on their length of service and rate of pay at the time of termination.
		1	The liability in respect of most of its employees is discharged by participating in a defined contribution pension plan and making regular deposits with a pension fund or by individual insurance policies. The liability deposited with the pension fund is based on salary components as prescribed in the existing labor agreement.  The custody and management of the amounts so deposited are independent of the companies and accordingly such amounts funded (included in expenses on an accrual basis) and related liabilities are not reflected in the balance sheet.
		2	The liability for severance pay which is not covered by the contribution plan amounted to $858 and $710 as of December 31, 2013 and 2012, respectively.
		3	Severance pay expenses were $1,081, $1,104, and $1,073 in 2013, 2012 and 2011, respectively.

Other_LongTerm_Liabilities

Other Long-Term Liabilities	12 Months Ended
	Dec. 31, 2013
Other Long-Term Liabilities [Abstract]	'
Other Long-Term Liabilities	'
	Note 14 - Other Long-Term Liabilities
			December 31,
			2013		2012
			U.S. Dollars
	Liability for contingent consideration in respect of
	business combinations (1)			1,762		4,968
	Liability to OCS, mainly in respect of business combinations (2)			3,996		5,281
				5,758		10,249
		-1	In accordance with ASC Topic 820 (Statement 157), the Company's liabilities for contingent consideration in respect of the acquisitions of Printar and SELA (see Note 23) are measured at fair value using Level 3 inputs. See Note 1B for the effect of the Company's decision regarding SELA's future operations.
		-2	Liability to OCS is in respect of the acquisitions of Printar, SELA and new grants received in 2010 and 2009. See Note 1B for the effect of the Company's decision regarding SELA's future operations.
	The effective interest rate used in the capitalization of the liabilities to the OCS in respect of the acquisitions of Printar and SELA as of December 31, 2013 were 10% and 21%, respectively. (As of December 31, 2012, 16% and 20%, for Printar and SELA, respectively).
		See Note 11 for current maturities of liability for contingent consideration and liability to OCS.

Commitments_and_Contingencies

Commitments and Contingencies

12 Months Ended

Dec. 31, 2013

Commitments and Contingencies [Abstract]

'

Commitments and Contingencies

'

Note 15 - Commitments and Contingencies

A.

Operating leases

The Company's subsidiaries have entered into various non-cancelable operating lease agreements, principally for office space. In addition, in 2013, the Company entered into a new framework agreement for non-cancelable operating leases for vehicles for a period of 36 months.

As of December 31, 2013, minimum future rental payments under such non-cancelable operating leases are as follows:

Year Ending

U.S. Dollars

December 31,

2014

1,533

2015

873

2016

416

Thereafter

-

2,822

Aggregate office rent expenses amounted to $1,002, $979, and $968 in 2013, 2012 and 2011, respectively.

B.

Allowance for doubtful debts

The following is a summary of the allowance for doubtful accounts related to accounts receivable for the years ended December 31:

Balance at

Balance at

beginning

Reversal of

Write-off of

end of

of period

Provision

provision

provision

period

U.S. Dollars

2011

3,854

357

(359

)

(1,625

)

2,227

2012

2,227

307

(140

)

(1,071

)

1,323

2013

1,323

272

(218

)

(16

)

1,361

C.

Litigation

1

On July 14, 2005, a lawsuit was filed against the Company in the United States District Court for the District of Minnesota ("Court") by one of the Company's competitors in the field of semiconductor wafer inspection equipment, August Technology Corporation (today Rudolph Technologies Inc., hereinafter "Rudolph", after August Technology's acquisition by Rudolph).  This suit alleged that the Company's Falcon inspection system infringed Rudolph's U.S. Patent No. 6,826,298 ("'298 Patent") and sought injunctive relief and damages. On March 6, 2009, a jury verdict in favor of Rudolph was rendered in this action, awarding Rudolph damages of approximately $6.8 million for the Company's sales of its Falcon products in the United States.  On August 28, 2009, the Court entered judgment ordering the Company to pay the jury award, and an additional $1.2 million in prejudgment interest. The Court also issued an injunction ("Injunction") prohibiting future sales and marketing of the Falcon product in the United States.  On January 7, 2011, the Court found that Rudolph was entitled to an additional supplemental award of $646 in damages for Falcon sales which occurred after the time period considered by the jury.

The Company appealed the Court's judgment to the United States Court of Appeals for the Federal Circuit on August 10, 2010, and posted a bond with the Court to stay collection of the judgment pending resolution of the appeal. On August 22, 2011, the Court of Appeals for the Federal Circuit found that the Minnesota trial court had erred in its instructions to the jury regarding the construction/meaning of a material claim term in the asserted '298 Patent and vacated the finding of infringement, the damages award and the Injunction. The Court of Appeals remanded the case to the Court for a limited trial based on a corrected claim construction.   If the jury finds that the Company infringes the '298 Patent, the Court could re-enter the original award of $8,023, and grant a supplemental award of $646. The court would also likely add additional interest to the award commencing as of the original judgment through a final judgment on the retrial. The parties are awaiting a trial date.

Although it is difficult to predict the outcome of this patent infringement case the Company believes that it has strong legal position and intends to continue to vigorously defend it in the District Court and in the Court of Appeals, if required. The total range of loss for this case is between $0 to $8.2 million (excluding interest) with respect to which the Company has not recorded any accruals.

On March 9, 2011, in conjunction with the '298 Patent infringement case, Rudolph filed a motion for contempt seeking approximately $1.2 million and unspecified attorneys' fees for alleged contempt of the Court's Injunction due to certain post verdict sales of Falcon systems.

On March 26, 2012, the Court issued an Order adopting the Magistrate Judge's Report and Recommendation issued August 11, 2011, on contempt and damages in a sum of $1,292. The Magistrate Judge also awarded Rudolph with $71 in attorney fees. The Court held that some of the Company's communications made during 2009 related to the eventual sale of some of its Falcon systems in Asia, were prohibited by the Injunction that was then in place (as mentioned above, the Injunction was vacated by the U.S. Court of Appeals for the Federal Circuit in August 2011). On April 10, 2012 Chief Judge Davis excused himself stating that he could no longer be "fair and impartial". On April 17, 2012 the Company filed a Rule 60 motion requesting that the contempt judgment be set aside for lack of due process. The New District Judge reduced the amount of sanctions award by half. The new judge denied the Company's request for a jury trial on contempt and sanctions. The Company has taken steps to appeal the sanctions award and submitted its opening appeal brief on November 30, 2012. On November 18, 2013 the Court of Appeals issued an opinion finding that the underlying contempt and sanctions findings were not final, appealable orders until after the resolution of the retrial of infringement of the '298 Patent infringement case in the Minnesota District Court. The Company deposited $729 with the Court as a bond while the appeal is pending. Although it is difficult to predict the outcome of this litigation, the Company believes that it has strong arguments against the current residual award of $646 and intends to vigorously continue the proceedings it initiated at the Court of Appeals in order to overturn this award. The total range of loss for this case is between $0 to $650 (excluding interest) in excess of amounts already accrued by the Company.

2

On December 27, 2011, Rudolph filed, but did not serve, a complaint in the Court charging the Company with infringement of Rudolph's U.S. Patent 7,779,528 ("'528 Patent") relating to semiconductor wafer inspection technology similar to that described in the '298 Patent.  On January 19, 2012, the Company filed a reexamination request with the U.S Patent and Trademark Office ("PTO") seeking reexamination of the '528 Patent. The PTO granted the reexamination request and preliminarily found that 18 claims were invalid. This PTO decision is not final and could change. On April 13, 2012, Rudolph served the '528 suit and agreed to stay the case until the completion of the reexamination. The parties presented the Court with a joint motion to stay the case. The Court has agreed to stay the case for 90 days at a time. The parties must reapply at the end of each stay period for a further stay. The case remains stayed at present. As Rudolph did not demand a specific dollar amount (but an accounting for damages and an injunction against infringing activity), the Company is unable to estimate the possible range of loss in this case and the effect on the Company's activities and results of operation, if any.

D.

Agreement with Bank Leumi L'Israel

In connection with the issuance of an appeal bond, in August 2010 the Company signed an agreement with Bank Leumi L'Israel, according to which the Bank provided a bank guarantee in the amount of $8,925 in order to support the appeal bond, which was issued by a surety company in the United States, together with a long-term loan of approximately $1,300  (see Note 12 - Long-term loan).  In addition, the Company received short-term loans in the amount of approximately $1,400 and factoring facilities of additional $1,300. As of December 31, 2013 these factoring facilities have not been utilized. The Company's obligations to the Bank were secured by a lien on its facility in Israel, restricted deposits in the amount of approximately $5,200 and a floating charge on its assets.

Following the Company's successful appeal in the infringement dispute with Rudolph, the appeal bond was officially released in September 2011. As such, the Bank ceased to provide the guarantee and the restrictions were removed from the deposits.

In addition, the Company signed a covenant agreement with the Bank, amended in December 2011, which requires it to comply with the following financial covenants:

·

On December 31 each year, the following covenants will be met:

1)

Adjusted shareholders' equity will be not less than 50% of the total balance sheet.(1)

2)

Adjusted shareholders' equity will be not less than $40,000. (1)

3)

Total annual sales will be not less than $60,000.

4)

From the date of the agreement, operating profits (EBITDA) will be positive.

-1

Adjusted shareholders' equity is defined in the agreement as shareholders' equity as presented in the financial statements, minus deferred expenses, intangible assets, and balances due from affiliates.

·

At the end of each quarter, the Company's cash balance will be not less than $11,500, including deposits and liens to Bank Leumi.

·

Total foreign assets of the Company at the end of each quarter will be greater than their total debts and liabilities.

·

The ratio of debt to banks to open receivables should be not greater than 70% at the end of each quarter.

·

No lien may be placed on any of its subsidiaries' assets without prior written approval from the Bank.

In addition, the Company made a commitment not to significantly change its majority shareholders without prior written permission from the Bank. Similarly, the Company committed not to perform a merger without written permission from the Bank.

As of December 31, 2013 and 2012, the Company was in full compliance with the amended financial covenants.

In accordance with the updated agreements, the Company's obligations to both Bank Leumi and Bank Mizrahi are secured pari passu by a lien on its facility in Israel and a fixed and floating charge on its assets.

E.

Agreement with Bank Mizrahi

In July 2011 the Company signed an agreement with Bank Mizrahi for a credit facility (see Notes 10, 12). The Company's obligations to the Bank were secured by a lien on its facility in Israel and a floating charge on its assets. In addition, the Company signed a covenant agreement with the Bank which requires it to comply with the following financial covenants:

At any time prior to the complete repayment of the credit, the Company is required to ensure:

·

The ratio of customers' balances and cash balances to its credit facilities including guarantees will not be less than 150%.

·

The ratio of the Company's credit facilities including guarantees to the total balance sheet will not exceed 20%.

·

Shareholders' equity will not be less than 40% of the total balance sheet.

·

Shareholders' equity will not be less than $40,000.

In the event that the Company is in breach of any of the covenants by no more than 10% it will be given two financial quarters to achieve compliance.

As of December 31, 2013 and 2012 the Company was in full compliance with these financial covenants.

F.           Chief Scientist

Through its acquisition of Printar and SELA, the Company participates in programs sponsored by the Israeli government for the support of research and development activities. The Company is committed to pay amounts to the Chief Scientist (OCS) at rates of 3.5% of the sales of products resulting from this research and development, up to an amount equal to 100% of the grants received by the Company, and for grants received after January 1, 1999 also bearing interest at the rate of LIBOR.

The obligation to pay these royalties is contingent on actual sales of the products and in the absence of such sales, no payment is required.

As of December 31, 2013 the amount of non-repaid grants received including interest accrued, in respect of Printar and SELA, amounted to $5,810 and $2,525, respectively (December 31, 2012 - $5,660  and $2,590 , respectively). The liabilities to the OCS were recorded at fair value as part of the purchase price allocation related to the acquisition of Printar and SELA and as of December 31, 2013 amounted to $3,303  and $202 , respectively (December 31, 2012 - $2,989 and $1,903 , respectively). (See Note 14 - Other long-term liabilities).

In 2009 and 2010, the Company received further grants in the amount of $598 ($650 including accrued interest) from the OCS in connection with the research and development activities related to the Printar acquisition.

G.           Dispute with Chief Scientist

A dispute has arisen between the Company and the OCS in Israel in the amount of approximately $755, including accrued interest, regarding the royalty rate to be paid in respect of certain of the Company's  products, the manufacturing and assembly of which has been moved to a foreign subsidiary.

Management, based on an opinion of its legal advisors, believes that the probability of an unfavorable resolution to this dispute is less than 50%. Accordingly, no accrual has been recorded in the financial statements in respect of this matter.

H.           Outstanding Purchase Orders

As of December 31, 2013, the Company has purchase orders of $6,085 (2012 - $7,938) which mainly represent outstanding purchase commitments for inventory components ordered by the Company in the normal course of business.

Concentration_of_Risk_and_Fina

Concentration of Risk and Financial Instruments	12 Months Ended
	Dec. 31, 2013
Concentration of Risk and Financial Instruments [Abstract]	'
Concentration of Risk and Financial Instruments	'
	Note 16 - Concentration of Risk and Financial Instruments
	Financial instruments that potentially expose the Company to concentrations of credit risk consist of cash equivalents, short-term bank deposits and trade receivables. The carrying amounts of financial instruments approximate fair value.
	Cash and cash equivalents
	The Company's cash equivalents are maintained with multiple high-quality institutions and the composition and maturities of investments are regularly monitored by management.
	Trade receivable
	The trade receivables of the Company are derived from sales to a large number of customers, primarily large industrial corporations located mainly in Asia, the United States and Europe. The Company generally does not require collateral: however, in certain circumstances, the Company may require a letter of credit, other collateral or additional guarantees. An allowance for doubtful accounts is determined with respect to those amounts that the Company has determined to be doubtful of collection. The Company performs ongoing credit evaluations of its customers.
	Trade payable
	The Company relies on limited source of suppliers and in some cases a sole supplier and/or subcontractors for a number of essential components and subsystems of its products. The Company does not have agreements with all of these suppliers and subcontractors for the continued supply of the components or subsystems they provide. An interruption in supply from these sources would disrupt production and adversely affect the Company's ability to deliver products to its customers, which could have an adverse effect on the Company's business, revenues and results of operations.
	Liquidity:
	The Company anticipates that its existing resources and cash flows from operations will be adequate to satisfy its liquidity requirements through calendar year 2014. If available liquidity will not be sufficient to meet the Company's operating and loan obligations as they become due, Management's plans include pursuing alternative financing arrangements or reducing expenditures as necessary to meet the Company's cash requirements throughout 2014. See also Note 15 (D) and Note 15 (E).
	Derivative Instruments
	The Company enters into foreign exchange instruments to manage its U.S. Dollar to NIS currency exchange risks. The terms of all of these currency instruments are less than one year. The notional amounts and fair value of derivatives as of December 31, 2013 are:
		Notional amount		Fair value
		U.S. Dollars
	Options
	Buy put options (Buy dollars and Sell NIS)		200		7
	Sell call options (Sell dollars and Buy NIS)		200		-
	The fair value of the instruments generally reflects the estimated amounts that the Company would receive or pay upon termination of the contracts at the reporting date.
	The Company's derivative instruments are measured at fair value on the measurement date using Level 2 inputs.
	Such instruments had a combined fair value loss of $(66) and gain of $608 for the years ended December 31, 2013 and 2012, respectively, based on quotations from financial institutions. The Company does not apply hedge accounting. Gains /losses on these instruments are recognized in the consolidated statement of operations.

Shareholders_Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2013
Shareholders' Equity [Abstract]	'
Shareholders' Equity	'
	Note 17 - Shareholders' Equity
	A.           General
	The Company shares are traded on the NASDAQ National Market under the symbol of CAMT, and also listed and traded on the Tel-Aviv stock exchange.
	B.           Purchase of Ordinary Shares
	On September 17, 2001, the Company announced that the Board of Directors authorized a share repurchase program to acquire up to $3,000 of the Company's ordinary shares from time to time in open market transactions. During September 2001, the Company purchased 250,000 ordinary shares at a cost of $592 and during 2002 the Company purchased 761,619 ordinary shares at a total cost of $401 in connection with such program.
	In 2008, the Board of Directors authorized a further share repurchase program Repurchases will not exceed a total aggregate price of $2,000. In 2008 1,080,757 shares were repurchased for an aggregate price of $905.
	C.           Stock Option Plan
	As of December 31, 2013, the Company has five stock option plans for employees and directors. Future options will be granted only pursuant to the 2003 Share Option Plan described below.
	In October 2003, the Company adopted a stock option plan (the Plan) pursuant to which the Company's Board of Directors may grant stock options to officers and key employees. The total number of options which may be granted to directors, officers, employees and consultants under this plan, is limited to 1,598,800 options. Stock options can be granted with an exercise price equal to or less than the stock's fair market value at the date of grant. All stock options have 10 year terms and vest and become fully exercisable after 4 years from the date of grant. On December 30, 2013, the Board of Directors elected to further extend the period of 2003 share option plan until June 30, 2015.
	As of December 31, 2013, there are 207,956 additional options available for grant under the Plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes-Merton option-pricing model that used the weighted average assumptions in the following table. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant.
			2013 Grant			2012 Grant
	Valuation assumptions:
	Dividend yield		0			0
	Expected volatility		64%-69%			63%
	Risk-free interest rate		1.74%			0.84%-0.92%
	Expected life (years)		6.4			6.2-6.4
	Vesting period (years)		4			4
		In the years ending December 31, 2013, 2012 and 2011, 75,000, 134,010 and 846,804 options were granted, respectively. The total grant date intrinsic value of options exercised during the years ended December 31, 2013, 2012, and 2011 $0.00, $0.00 and $0.00 respectively. The total grant date intrinsic value of options vested at December 31, 2013 was $54.
		The total stock option compensation expense amounted to $361, $329, and $297 in 2013, 2012 and 2011, respectively.
	As of December 31, 2013, there was $450 of total unrecognized compensation cost related to nonvested share-based compensation arrangements. That cost is expected to be recognized over a weighted-average period of 1.9 years.
	Share option activity during the past three years is as follows:
			Year Ended December 31,
			2013							2012					2011
							Weighted						Weighted					Weighted
			Number				average			Number			average		Number			average
			of				exercise			of			exercise		Of			exercise
			options				price US$			options			price US$		options			price US$
	Outstanding at January 1			1,195,085				3.15			1,234,199			3.31		489,701			3.21
	Granted			75,000				1.73			134,010			1.6		846,804			3.35
	Forfeited and cancelled			(174,915	)			2.96			(173,124	)		3.11		(53,400	)		3.35
	Exercised			(359,651	)			3.26			-			-		(48,906	)		2.98
	Outstanding at year end			735,519				2.99			1,195,085			3.15		1,234,199			3.31
	Vested at year end			368,016				3.42			395,395			3.29		412,395			3.26
										Weighted			Aggregate
			Number				Weighted			Average			intrinsic
			of				average			Remaining			Value (in
			options				exercise			Contractual			US$
			outstanding				price US$			term (years)			thousands)
	Outstanding as of December 31, 2013			735,519				2.99			7.21			813
	Vested and expected to vest at
	December 31, 2013			676,677				2.99			7.21			748
	Exercisable at December 31, 2013			368,016				3.42			6.22			275
	The following table summarizes information about share options at December 31, 2013:
											Weighted
											average
				Number of							remaining
				outstanding				Number			contractual
	Exercise price US$			options				exercisable			life in years
	0-2				204,190				30,180			9.08
	5-Mar				521,329				327,836			6.56
	7-Jun				10,000				10,000			2.58
					735,519				368,016			7.21
	The following table summarizes information about nonvested options at December 31, 2013:
							Weighted
							average
							grant- date
			Options				fair value
	Balance at January 1, 2013			799,690				1.8
	Granted			75,000				1.19
	Vested			(420,277	)			2.17
	Forfeited			(86,910	)			1.5
	Balance at December 31, 2013			367,503				1.32
		D.	Restricted Share Unit Plan
In August 2007, the Company adopted a Restricted Share Unit ("RSU") Plan (the "Plan") pursuant to which the Company's Board of Directors may grant shares to officers and key employees. The total number of shares, which may be granted to directors, officers, employees and consultants under this Plan, is limited to 1,500,000 authorized but unissued Shares, after it was increased in 2009 by an additional 1,200,000 from 300,000 authorized but unissued shares.
The exercise price for each grantee shall be as determined by the Board and specified in the applicable RSU notice of grant; provided, however, that unless otherwise determined by the Board (which determination shall not require shareholder approval unless so required in order to comply with Mandatory Law), the exercise price shall be no more than the underlying share's nominal value. For the removal of any doubt, the Board is authorized (without the need for shareholder approval unless so required in order to comply with Mandatory Law) to determine that the exercise price of an RSU is to be $0.00.
Unless otherwise determined by the Board with respect to any specific grantee or to any specific grant, (which determination shall not require shareholder approval unless so required in order to comply with Mandatory Law) and provided accordingly in the applicable RSU notice of grant, the RSUs shall vest (become automatically exercised) according to the following 4-year vesting schedule:
	a.	Upon the completion of a full 12 (twelve) months of continuous service - 25%.
	b.	Upon the lapse of each full additional 3 (three) months of the grantee's continuous service thereafter, until all the RSU are vested, i.e. 100% of the grant will be vested after 4 years. - 6.25%  per quarter.
2009 grant vesting schedule as determined by the Board in April 2009 is as follows:
	a.	Upon the completion of a full 24 (twenty four) months of continuous service - 50%.
	b.	Upon the completion of a full 12 (twelve) months of continuous service - 25%.
	c.	Upon the completion of a full 12 (twelve) months of continuous service - 25%.
Forfeited units are returned to the pool.
Total share based awards expense amounted to $19, $72, and $120 in 2013, 2012 and 2011, respectively.
The total unrecognized compensation cost amounted to $0.
As of the balance sheet date the number of RSU's available for grant was 670,129.
Activity under the Restricted Share Unit Plan was as follows:
		Awards				Number of			Weighted-
		available				awards			average
		for grant				outstanding			fair value US$
Balance as of December 31, 2012			665,825				153,246			0.39
Awards granted			-				-			-
Exercised			-				(148,942	)		0.39
Forfeited			4,304				(4,304	)		0.38
Balance as of December 31, 2013			670,129				-			-

Earnings_Per_Ordinary_Share

Earnings Per Ordinary Share	12 Months Ended
	Dec. 31, 2013
Earnings Per Ordinary Share [Abstract]	'
Earnings Per Ordinary Share	'
	Note 18 - Earnings Per Ordinary Share
	The following table summarizes information related to the computation of basic and diluted earnings per Ordinary Share for the years indicated:
		Year Ended December 31,
		2013		2012		2011
		U.S. Dollars (In thousands, except per share data)
	Net income attributable to Ordinary Shares		7		3		5,378
	Weighted average number of Ordinary Shares
	outstanding used in basic earnings per Ordinary
	Share calculation		30,040		29,849		29,557
	Add assumed exercise of outstanding dilutive
	potential Ordinary Shares		54		164		452
	Weighted average number of Ordinary Shares
	Outstanding used in diluted earnings per Ordinary
	Share calculation		30,094		30,013		30,009
	Basic income per Ordinary Share		0		0		0.18
	Diluted income per Ordinary Share		0		0		0.18
	Number of options excluded from the diluted
	earnings per share calculation due to their
	anti-dilutive effect		526		976		1,082

Geographic_Information

Geographic Information	12 Months Ended
	Dec. 31, 2013
Geographic Information [Abstract]	'
Geographic Information	'
	Note 19 - Geographic Information
	Substantially all fixed assets are located in Israel and substantially all revenues are derived from shipments to other countries. Revenues are attributable to geographic areas/countries based upon the destination of shipment of products and related services as follows:
		Year Ended December 31,
		2013		2012		2011
		U.S. Dollars
	China and Hong Kong		25,889		25,008		34,113
	Korea		15,691		17,004		23,233
	Asia- Other		6,072		10,739		7,487
	United States		11,705		9,482		11,699
	Taiwan		14,543		11,292		16,458
	Western Europe		6,519		6,998		6,956
	Japan		4,010		2,370		4,618
	Rest of the world		976		1,654		2,464
			85,405		84,547		107,028

Selected_Income_Statement_Data

Selected Income Statement Data	12 Months Ended
	Dec. 31, 2013
Selected Income Statement Data [Abstract]	'
Selected Income Statement Data	'
	Note 20 - Selected Income Statement Data
	A.           Revenues
		Year Ended December 31,
		2013			2012			2011
		U.S. Dollars
	Printed Circuit Boards and
	IC substrates		19,442			16,479			30,708
	Microelectronics		48,422			50,450			57,696
	Service fees		17,541			17,618			18,624
	Total Revenues		85,405			84,547			107,028
	B.           Selling, general and administrative expenses
		Year Ended December 31,
		2013			2012			2011
		U.S. Dollars
	Selling (1)		13,906			13,827			15,614
	General and administrative		8,456			7,311			8,727
			22,362			21,138			24,341
	(1)           Including shipping and handling costs		652			1,076			1,469
	C.           Financial income (expenses), net
		Year Ended December 31,
		2013			2012			2011
		U.S. Dollars
	Interest expense		(181	)		(163	)		(100	)
	Interest income		90			38			32
	Re-evaluation of contingent consideration		(858	)		1,037			(1,264	)
	Interest expense on liabilities to the OCS		(504	)		(667	)		(791	)
	Other, net		(285	)		(12	)		(777	)
			(1,738	)		233			(2,900	)
	Other, net includes foreign currency income (expense) resulting from transactions not denominated in U.S. Dollars amounting to $(188), $84, and $(308) in 2013, 2012 and 2011, respectively.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]	'
Income Taxes	'
	Note 21 - Income Taxes
		A.	Tax under various laws
			The Company and its subsidiaries are assessed for tax purposes on a separate basis. Each of the subsidiaries is subject to the tax rules prevailing in the country of incorporation.
		B.	Details regarding the tax environment of the Israeli companies
		-1	Corporate tax rate
	Presented hereunder are the tax rates relevant to the Company in Israel for the years 2011-2013:
			2011 - 24%
			2012 - 25%
			2013 - 25%
	On August 5, 2013 the Knesset passed the Law for Changes in National Priorities (Legislative Amendments for Achieving Budget Objectives in the Years 2013 and 2014) - 2013, by which, inter alia, the corporate tax rate would be raised by 1.5% to a rate of 26.5% as from 2014.
	Current taxes for the reported periods are calculated according to the tax rates presented above, subject to the benefit under the Law for the Encouragement of Capital Investment.
		-2	Benefits under the Law for the Encouragement of Capital Investments (hereinafter - "the Encouragement Law")
	(a)           Beneficiary enterprise
	An industrial enterprise of the Company and a certain subsidiary were granted "Beneficiary Enterprise" status in accordance with the Encouragement Law. The Company has chosen 2005 and 2010 as the years of election.
	The income generated by the "Beneficiary Enterprise" is exempt from tax over a period of up to 10 years beginning with the year in which the Company first had taxable income and subject to the years of election (limited to the earlier of a maximum period of 12 years from the year of election). The tax benefit period of the beneficiary enterprise that commenced operations in 2005 and 2007 will end in 2014 and 2016, respectively, whereas the benefit period of the beneficiary enterprise that commenced operations in 2010 will end in 2021. The benefits are contingent upon compliance with the terms of the Encouragement Law, such provisions generally require that at least 25% of the Beneficiary Enterprise's income will derive from export. The Company is currently in compliance with these terms.
	A company having a beneficiary enterprise that distributes a dividend from exempt income, will be required in the tax year of the dividend distribution to pay income tax on the amount of the dividend distributed at the tax rate that would have been applicable to it in the year the income was produced if it had not been exempt from tax.
		(b)	Amendment to the Law for the Encouragement of Capital Investments - 1959
	On December 29, 2010 the Knesset approved the Economic Policy Law for 2011-2012, which includes an amendment to the Law for the Encouragement of Capital Investments - 1959 (hereinafter - "the Amendment"). Companies could choose not to be included in the scope of the Amendment to the Encouragement Law and to stay in the scope of the law before its amendment until the end of the benefits period of its approved/beneficiary enterprise. The Company has decided not to be included in the scope of the Amendment in respect of its applicable benefit programs.
	On August 5, 2013 the Knesset passed the Law for Changes in National Priorities (Legislative Amendments for Achieving Budget Objectives in the Years 2013 and 2014) - 2013, which determined that as of 2014 tax year the tax rate on preferred income will be 9% for Development Area A and 16% for the rest of the country.
		(c)	The Company intends to indefinitely reinvest the amount of its tax-exempt income and not distribute any amounts of its undistributed tax exempt income as dividend. Accordingly, no deferred tax liabilities have been provided on income attributable to the Company's Approved and Beneficiating Enterprise Programs.
		Out of Camtek's retained earnings as of December 31, 2013 approximately $20,600 are tax-exempt earnings attributable to its Approved Enterprise and approximately $9,400 are tax-exempt earnings attributable to its Beneficiating Enterprise. The tax-exempt income attributable to the Approved and Beneficiating Enterprises cannot be distributed to shareholders without subjecting the Company to taxes. If these retained tax-exempt profits are distributed, the Company would be taxed at the reduced corporate tax rate applicable to such profits (currently - 25% pursuant to the implementation of the Investment Law). According to the Amendment, tax-exempt income generated under the Beneficiating Enterprise will be taxed upon dividend distribution or complete liquidation, whereas tax exempt income generated under the Approved Enterprise will be taxed only upon dividend distribution (but not upon complete liquidation, as the tax liability will be incurred by the shareholders).\
		As of December 31, 2013, if the income attributed to the Approved Enterprise was distributed as dividend, the Company would incur a tax liability of approximately $5,200 million. If income attributed to the Beneficiary Enterprise was distributed as dividend, or upon liquidation, the Company would incur a tax liability in the amount of approximately $2,300 million. These amounts will be recorded as an income tax expense in the period in which the Company declares the dividend.
		C.	Details regarding the tax environment of the Non Israeli companies
	Non Israeli subsidiaries are taxed according to the tax laws in their countries of residence as reported in their statutory financial statement prepared under local accounting regulations.
	The subsidiaries in China were entitled to 50% tax reduction from the standard tax rate of 25% for a period of time. The tax rate for both Chinese subsidiaries in 2011 was 12%-12.5%. The tax holidays ended in 2012 for Camtek Electronic Technology ("CET") and ended in 2013 for Camtek Imaging Technology ("CIT").
	As of December 31, 2013, Camtek has not provided for income taxes on the undistributed earnings of approximately $14,362 of two of its major foreign subsidiaries since these earnings are intended to be indefinitely reinvested. A deferred tax liability will be recognized when the Company no longer demonstrates that it plans to indefinitely reinvest these undistributed earnings. It is not practicable to estimate the amount of additional taxes that might be payable on such undistributed earnings. The Company's management has determined not to distribute any amounts of its undistributed income as a dividend if such distribution would result in a tax liability.
		D.	Composition of income (loss) before income taxes and income tax expense (benefit)
			Year Ended December 31,
			2013			2012			2011
			U.S. Dollars
	Income (loss) before income taxes:
	Israel			(2,638	)		(1,299	)		677
	Non-Israeli			2,036			1,512			5,445
				(602	)		213			6,122
	Income tax expense (benefit):
	Current:
	Israel			121			44			45
	Non-Israeli			709			398			735
				830			442			780
	Deferred:
	Israel			(1,287	)		-			-
	Non-Israeli			(152	)		(232	)		(36	)
				(1,439	)		(232	)		(36	)
				(609	)		210			744
	E.           Reconciliation of statutory tax expense to actual income tax
	The following is a reconciliation of the theoretical income tax expense, assuming all income is taxed at the statutory tax rate applicable to Israeli companies, and the actual income tax expense:
			Year Ended December 31,
			2013			2012			2011
			U.S. Dollars
	Income (loss) before income taxes			(602	)		213			6,122
	Statutory tax rate			25	%		25	%		24	%
	Theoretical income tax expense  (benefit)			(151	)		53			1,469
	Increase (decrease) in income tax expense resulting from:
	Tax expense (benefits) arising from "Approved and
	Beneficiating Enterprises" and preferential tax rate in China			711			492			3,347
	Change in valuation allowance(*)			586			(983	)		(5,423	)
	Non-deductible expenses(**)			218			650			139
	Differences between Israeli currency
	and dollar-adjusted financial statements-net			(1,133	)		160			686
	Purchase price adjustment for contingent liabilities			(580	)		-			-
	Foreign tax rate differential			(101	)		29			(11	)
	Other			( 159	)		(191	)		537
	Actual income tax expense (benefit)			(609	)		210			744
Per share effect of the tax benefits arising from
"Approved and Beneficiating Enterprises" and
preferential tax rate in China:
Basic		$	0		$	0.02		$	0.11
Diluted		$	0		$	0.02		$	0.11
	(*)	In 2013 an amount of $1,780 is a decrease in tax expense in respect to a change in the effective tax rate from Beneficiary enterprise and an amount of $338 is an increase in tax expense resulting from losses not available for future years. In addition, Included within the change in valuation allowance are realized benefits of operating loss carryforwards of $68, $635 and $2,007, for the years ended December 31, 2013, 2012 and 2011, respectively.
	(**)	Including non-deductible share based compensation.
F.             Deferred taxes
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are presented below:
		December 31,
		2013			2012
		U.S. Dollars
Deferred tax assets:
Allowance for doubtful accounts			96			82
Accrued warranty			109			26
Unearned revenue			151			182
Accrued expenses			303			370
Net operating losses (NOL) and tax credit carryforwards			4,398			4,258
Other temporary differences*			663			1,027
Total gross deferred tax assets			5,720			5,945
Valuation allowance			(3,609	)		(5,141	)
Deferred tax asset, net of valuation allowance			2,111			804
Deferred tax liability:
Property, plant and equipment			(198	)		(330	)
Net deferred tax assets			1,913			474
*          Other temporary differences primarily relate to research and development expenses
Deferred tax assets are to be recognized for the anticipated tax benefits associated with net operating loss carryforwards and deductible temporary differences, unless it is more likely than not that some or all of the deferred tax assets will not be realized. The adjustment is made by a valuation allowance.
In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.
At December 31, 2013 and 2012 the Company had valuation allowance of $3,609 and $5,141 on certain of deferred tax assets. The net change in the total valuation allowance was a decrease of $1,532, $983 and $5,423 for the years ended December 31, 2013, 2012 and 2011, respectively. During the year, the Company determined that the benefits of certain Israel and foreign beginning of the year deferred tax assets were more likely than not to be realized in future years, based on consideration of business trends and forecasts.  Accordingly, the Company reversed the valuation allowances on these affiliates, in the amount of $1,344. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced.
As of December 31, 2013, the Company and its subsidiaries in Israel have regular NOL carryforwards aggregating approximately $65,069 that will not expire.
As of December 31, 2013, the major foreign subsidiaries have NOL carryforwards aggregating approximately $3,632, of which approximately $2,192 will expire from 2013 to 2028 and approximately $1,440 can be carried forward indefinitely.
G.            Accounting for uncertainty in income taxes
For the years ended December 31, 2013, 2012 and 2011, the Company did not have any significant unrecognized tax benefits. In addition, the Company does not expect that the amount of unrecognized tax benefits will change significantly within the next twelve months.
The Company accounts for interest and penalties related to an underpayment of income taxes as a component of income tax expense. For the years ended December 31, 2013, 2012 and 2011, no interest and penalties related to income taxes have been accrued.
H.            Tax Assesments
The Company and its subsidiaries in Israel file their income tax returns in Israel while its principle foreign subsidiaries file their income tax returns in Belgium, Hong Kong, United States of America and China. The Israeli tax returns of Camtek are open to examination by the Israeli Tax Authorities for the tax years beginning in 2008, in addition, the Israeli tax returns of SELA are open to examination by the Israeli Tax Authorities for the tax years beginning in 2008, while the tax returns of its principal foreign subsidiaries remain subject to examination for the tax years beginning in 1999 in Belgium, 2007 in Hong Kong and 2010 in the United States of America.

Balances_and_Transactions_with

Balances and Transactions with Related Parties	12 Months Ended
	Dec. 31, 2013
Balances and Transactions with Related Parties [Abstract]	'
Balances and Transactions with Related Parties	'
	Note 22  -   Balances and Transactions with Related Parties
	A.            Balances with related parties:
		December 31,		December 31,
		2013		2012
		U.S. Dollars
	Accounts receivable		43		-
	Accounts payable		6		-
	Due from affiliated companies		233		391
	B.            Transactions with related parties:
		Year Ended December 31,
		2013		2012		2011
		U.S. Dollars
	Purchases from Parent and affiliates		57		-		1,555
	Interest income from Parent		4		15		31
	Sales to Parent and affiliated companies		347		142		2,397
	Unpaid balances between Parent and its subsidiaries in Israel and the Company bear interest of 5.5%.

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2013
Fair Value Measurements [Abstract]	'
Fair Value Measurements	'
	Note 23 - Fair Value Measurements
	The level in the fair value hierarchy within which an asset or liability is classified is based on the lowest level input that is significant to the fair value measurement in its entirety.
	The Company measures its foreign currency derivative contracts and its long-term liabilities with respect to contingent consideration at fair value. The Company's foreign currency derivative contracts are classified within Level 2, because they are valued utilizing market observable inputs. The long-term liabilities arising from contingent consideration are classified within Level 3 because they are valued using significant inputs that are unobservable in the market such as the Company's weighted average cost of capital.
	The following table presents the Company's assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and December 31, 2012, aggregated by the level in the fair-value hierarchy within which those measurements fall:
					Quoted Prices in				Significant
					Active Markets for		Significant Other		Unobservable
		December 31,			Identical Assets		Observable Inputs		Inputs
	Description	2013			(Level 1)		(Level 2)		(Level 3)
		U.S. Dollars
	Assets
	Foreign currency derivative contracts		7			-		7		-
	Total Assets		7			-		7		-
	Liabilities
	Contingent consideration		2,030			-		-		2,030
	Total Liabilities		2,030			-		-		2,030
					Quoted Prices in				Significant
					Active Markets		Significant Other		Unobservable
		December 31,			for Identical Assets		Observable Inputs		Inputs
	Description	2012			(Level 1)		(Level 2)		(Level 3)
		U.S. Dollars
	Assets
	Foreign currency derivative contracts		74			-		74		-
	Total Assets		74			-		74		-
	Liabilities
	Contingent consideration		5,303			-		-		5,303
	Total Liabilities		5,303			-		-		5,303
	The Company's accounting policy is to recognize transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. There were no transfers into or out of level 1, level 2, or level 3 for the year ended December 31, 2013.
	The following tables present a roll-forward of the fair value of Level 3 (significant unobservable inputs) liabilities for the year ended December 31, 2013 and 2012:
		Level 3
		U.S. Dollars
		Contingent consideration
	31-Dec-12		5,303
	Settlement of liabilities		(639	)
	Revaluation of fair value included in statement of operations		(2,634	)
	31-Dec-13		2,030
		Level 3
		U.S. Dollars
		Contingent consideration
	31-Dec-11		6,887
	Settlement of liabilities		(547	)
	Revaluation of fair value included in statement of operations		(1,037	)
	31-Dec-12		5,303
	The adjustments to fair value of the contingent consideration are recorded in the finance income (expense), net in the statement of operations.
	The fair value of the contingent payment for Printar as of December 31, 2013, was based on the $2,000 outstanding of the $2,500 transaction price, discounted from the estimated payment dates to the valuation date using the weighted average cost of capital of 28%. That measure is based on significant inputs that are not observable in the market, which ASC Section 820-10-35 refers to as Level 3 inputs. Key assumptions include management's estimation about future sales.
	The fair value of the contingent consideration arrangement for SELA as of December 31, 2013, was estimated based on future earn-out payments discounted to the valuation date using the weighted average cost of capital of 21%. That measure is based on significant inputs that are not observable in the market, which ASC Section 820-10-35 refers to as Level 3 inputs. Key assumptions include management's estimation about future sales.

Post_Balance_Sheet_Events

Post Balance Sheet Events	12 Months Ended
	Dec. 31, 2013
Post Balance Sheet Events [Abstract]	'
Post Balance Sheet Events	'
	Note 24 - Post Balance Sheet Events
		A.	On January 6, 2014, the Company's Chief Executive Officer, Mr. Roy Porat, informed the Board of Directors of his decision to step down from his position. The Board decided that upon the conclusion of a limited transition period and subject to shareholders approval, all responsibilities previously held by Mr. Porat shall be delegated to Mr. Rafi Amit in his capacity as Active Chairman of the Board, without any further amendment of his terms of employment.

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Significant Accounting Policies [Abstract]	'
Principles of consolidation	'
		B.	Principles of consolidation
	The accompanying consolidated financial statements include the accounts of Camtek and its subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.
Use of estimates	'
	C.	Use of estimates
	The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. As applicable to these financial statements, the most significant estimates and assumptions relate to revenue recognition, valuation of accounts receivable, inventories, intangible assets and goodwill, other long-lived assets, deferred tax assets, legal contingencies, contingent consideration and share based compensation among others. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. It is often difficult to accurately estimate the ultimate outcome of a contingent liability. Different variables can affect the timing and amount that management provides for certain contingent liabilities. The Company's assessments are therefore subject to estimates made by management and its legal counsel. Adverse revision in management estimates of the potential liability could materially impact the Company's financial condition, results of operations or liquidity.
	The Company adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.
Foreign currency transactions	'
	D.	Foreign currency transactions
	The functional currency of the Company and its subsidiaries is the U.S. Dollar. Revenue generated by the Company and its subsidiaries is primarily generated outside of Israel and a majority thereof is received in U.S. Dollars. In addition, materials and components purchased and marketing expenses incurred are either paid for in U.S. Dollars or in New Israeli Shekels ("NIS") linked to changes in the U.S. Dollar/NIS exchange rate.
	Transactions not denominated in U.S. Dollars are recorded upon their initial recognition according to the exchange rate in effect on the date of the transaction. Exchange rate differences arising upon the settlement of monetary items or upon reporting the Company's monetary items at exchange rates different from that by which they were initially recorded during the period, or reported in previous financial statements, are charged to financial income (expenses), net.
Cash and cash equivalents	'
		E.	Cash and cash equivalents
	All highly liquid investments purchased with original maturities of three months or less are considered to be cash equivalents.
Trade accounts receivable and allowance for doubtful accounts	'
	F.	Trade accounts receivable and allowance for doubtful accounts
	Accounts receivable are recorded at the outstanding recognized amount and do not bear interest. The allowance for doubtful accounts represents Management's best estimate of the probable loss inherent in existing accounts receivable balances as a result of possible non-collection. In determining the appropriate allowance, Management bases its estimate on information available about specific debtors, including aging of the balance, assessment of the underlying security received, the history of write-offs, relationships with the customers and the overall creditworthiness of the customers.
Inventories	'
	G.	Inventories
	Inventories consist of completed systems, partially completed systems and components and other raw materials, and are recorded at the lower of cost or market. Cost is determined by the moving - average cost method basis.
	Inventory write-downs are recorded at the end of each fiscal period for damaged, obsolete, excess and slow-moving inventory. These write-downs, to the lower of cost or market value, create a new cost basis that is not subsequently marked up based on changes in underlying facts and circumstances.
	Management periodically evaluates its inventory composition, giving consideration to factors such as the probability and timing of anticipated usage and the physical condition of the items, and then estimates a charge (reducing the inventory) to be provided for slow moving, technological obsolete or damaged inventory. These estimates could vary significantly, from actual requirements based upon future economic conditions, customer inventory levels or competitive factors that were not foreseen or did not exist when the inventory write-downs were established.
	Inventory that is not expected to be converted or consumed within the next year is classified as non-current, based on Management's estimates taking into account market conditions.
Property, plant and equipment	'
	H.	Property, plant and equipment
	These assets are stated at cost less accumulated depreciation, and are depreciated over their estimated useful lives on a straight-line basis.
	Annual rates of depreciation are as follows:
	Building			2	%
	Machinery and equipment			10% - 33	%
	Computer equipment and software			20%-33	%
	Office furniture and equipment			6% - 20	%
	Automobiles			15	%
	Leasehold improvements are amortized by the straight-line method over the shorter of the lease term or the estimated useful economic life of such improvements.
	Certain of the Company's finished goods are systems used as demonstration systems, training systems, and for product development in the Company's laboratories ("internal use"). These systems are identical to the systems that Camtek sells in its ordinary course of business. In circumstances where the Company intends to utilize such systems for its internal use, the Company transfers them from inventory to fixed assets. The rationale for the transfer is that the Company does not have the intention to sell these systems in the ordinary course of business but rather expects to use them for its internal use over their expected useful lives. These systems are recorded as fixed assets at cost and depreciated over their useful lives.
Intangible assets	'
		I.	Intangible assets
	Patent registration costs are recorded at cost and amortized, beginning with the first year of utilization, over its expected useful life.
	Intangible assets purchased as part of the business combinations were recorded at their fair value and are amortized based on their remaining estimated useful lives. Acquired in-process research and development (IPR&D) will be amortized starting at the initial date of recording revenues from the associated technology.
Impairment of long-lived assets	'
		K.	Impairment of long-lived assets
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of the long lived asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized to the extent that the asset's carrying amount exceeds its fair value (See Note 9).
Goodwill	'
	J.	Goodwill
	Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is reviewed for impairment at least annually in accordance with the provisions of FASB ASC Topic 350, Intangibles - Goodwill and Other. The goodwill impairment test is a two ­step test. Under step one, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the entity must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit's goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to an acquisition price allocation and the residual fair value after this allocation is the implied fair value of the reporting unit goodwill. Fair value of the reporting unit is determined using a discounted cash flow analysis. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed.
	The Company has set its annual impairment testing date at December 31. As of December 31, 2013 and 2012, based on the Company's annual impairment test, impairment charges were recognized. (See Note 9).
Fair values of financial instruments	'
		L.	Fair values of financial instruments
	The carrying amounts of the Company's financial instruments, including cash and cash equivalents, short-term deposits, trade accounts receivable, trade accounts payable, short-term liabilities to banks and amounts from affiliates approximate fair value because of their short-term maturities.
	The fair value of the long-term restricted deposit approximates the carrying amount, since it bears floating rate interest at the market rate.
	The fair value of long-term liabilities to banks also approximate the carrying amounts, since they bear floating rate interest at rates close to prevailing market rates.
	The contingent consideration liabilities relating to the Company's business combinations are measured at fair value at each balance sheet date.
Revenue recognition	'
	M.	Revenue recognition
	The Company recognizes revenue from sales of its products when the products are installed at the customer's premises and are operating in accordance with its specifications, signed documentation of the arrangement, such as a signed contract or purchase order, has been received, the price is fixed or determinable and collectibility is reasonably assured.
	In the limited circumstances when the products are installed by a trained distributor acting as an end user, revenue is recognized upon delivery to the distributor assuming all other criteria for revenue recognition are met.
	Service revenues consist mainly of revenues from maintenance contracts and are recognized ratably over the contract period.
	The Company implements the provisions of ASU 2009-13, Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements, and therefore for multiple-element arrangements the overall arrangement fee is allocated to each element (both delivered and undelivered elements) based on management's best estimate of their selling price where other sources of evidence are unavailable. The revenue relating to the undelivered elements is deferred using the relative selling price method utilizing vendor-specific-objective evidence ("VSOE") until delivery of the deferred elements.
	The Company's multiple deliverable arrangements consist of product sales and non-standard warranties. A non-standard warranty is one that is for a period longer than 12 months. Accordingly, income from a non-standard warranty is deferred as unearned revenue and is recognized ratably as revenue commencing with and over the applicable warranty term.
	The Company routinely evaluates its products for inclusion of any embedded software that is more than incidental thereby requiring consideration of ASC Subtopic 985-605, "Software Revenue Recognition".  Based on such evaluation, the Company has concluded that none of its products have such embedded software.
Warranty	'
	N.           Warranty
	The Company records a liability for standard product warranty obligations at the time of sale based upon historical warranty experience. The term of the warranty is generally twelve months.
	For the Company's treatment of non-standard warranties, see Note 2(M) - Revenue recognition.
Income taxes	'
	O.           Income taxes
	The Company accounts for income taxes in accordance with the asset and liability method whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. However, the Company does not recognize deferred taxes for differences related to assets and liabilities that are remeasured from the local currency into the functional currency using historical exchange rates and that result from changes in exchange rates or indexing for tax purposes. The Company presents foreign currency transaction gains and losses from remeasuring income tax assets and liabilities with income tax (benefit) expense. The Company provides a valuation allowance to reduce deferred tax assets to the amount that is more likely than not to be realized.
	The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is more than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.
Research and development	'
	P.           Research and development
	Research and development costs are expensed as incurred.
Earnings / loss per ordinary share	'
	Q.           Earnings / loss per ordinary share
	Basic earnings/loss per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year.  Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options, warrants and convertible loan.
	For the years ended December 31, 2013, 2012 and 2011, the effect of the exercise of outstanding dilutive potential share options and Restricted Share Units ("RSUs") has been included in computing dilutive earnings per ordinary share (see Note 18).
Share-based compensation	'
	R.           Share-based compensation
	The Company accounts for its employee share-based compensation as an expense in the financial statements. All awards are equity classified and therefore such cost is measured at the grant date fair value of the award. The Company estimates share option grant date fair value using the Black-Scholes-Merton option-pricing model. (For details see Note 17).
Fair value measurements	'
		S.	Fair value measurements
	The Company implements the provisions of ASC Topic 820 "Fair Value Measurements and Disclosures" ("ASC 820"). ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:
	Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
	Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
	Level 3 inputs are unobservable inputs for the asset or liability. (For details see Note 23).
Derivative instruments	'
	T.	Derivative instruments
	The Company enters into option contracts and forward exchange agreements in order to reduce its exposure with respect to various commitments in currencies other than the dollar, in connection with expenses in New Israeli Shekels.
	The Company does not issue or hold derivative financial instruments for trading purposes, but rather to manage its foreign currency exposure.  Nevertheless, these transactions do not meet all the conditions for hedge accounting and accordingly, the changes in fair value of such instruments are recorded directly to financial income (expenses), net.
	The Company's foreign exchange derivative contracts are marked-to-market based on the determined fair value of open contracts at period end. (See Note 16).
Contingent liabilities	'
		U.	Contingent liabilities
	A contingency (provision) in accordance with ASC Topic 450-10-05, Contingencies, is an existing condition or situation involving uncertainty as to the range of possible loss to the entity.
	A provision for claims is recognized if it is probable (likely to occur) that a liability has been incurred and the amount can be estimated reasonably.
Government-sponsored research and development	'
	V.	Government-sponsored research and development
	The Company records grants received from the Office of the Chief Scientist of the Israeli Ministry of Industry and Trade (the "OCS") as a liability, if it is probable that the Company will have to repay the grants received. If it is not probable that the grants will be repaid, the Company records the grants as a reduction to research and development expenses. Royalties paid to the OCS are recognized as a reduction of the above liability.
	The Company accounts for OCS liabilities acquired in business combinations within the confines of debt obligations and as such changes in the liability from period to period, caused by changes to the estimated timing of future repayments and accrued interest, are accounted for prospectively and recorded as financial expenses (income). (See Note 14 and Note 15F).
Recently issued and adopted accounting standards	'
	W.	Recently issued and adopted accounting standards
	In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. ASU 2013-11 requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. ASU 2013-11 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The new standard is to be applied prospectively but retrospective application is permitted.  The Company will implement the provisions of ASU 2013-11 as of January 1, 2014.

Nature_of_Operations_Tables

Nature of Operations (Tables)	12 Months Ended
	Dec. 31, 2013
Nature of Operations [Abstract]	'
Schedule of Details of Impairment	'
	The impact of this decision on the consolidated statement of income was as follows:
			Year ended
			December 31,
			2013
			U.S. Dollars in
	Account	Nature of impact	millions
	Cost of Revenues	Inventory write-off		3.1
	Reorganization and impairment	Impairment charge with respect of technology, customer relationships and goodwill		1.7
	Reorganization and impairment	Revaluation of liabilities in respect of SELA acquisition		(5.1	)
	Relevant areas in consolidated statement of income	Other (mainly due to disposal of fixed assets)		0.8
				0.5

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Significant Accounting Policies [Abstract]	'
Annual Rates of Depreciation	'
	Annual rates of depreciation are as follows:
	Building	2	%
	Machinery and equipment	10% - 33	%
	Computer equipment and software	20%-33	%
	Office furniture and equipment	6% - 20	%
	Automobiles	15	%

Cash_and_Cash_Equivalents_Tabl

Cash and Cash Equivalents (Tables)	12 Months Ended
	Dec. 31, 2013
Cash and Cash Equivalents [Abstract]	'
Cash and Cash Equivalents	'
		December 31,
		2013		2012
		U.S. Dollars
	Bank balances		16,405		13,790
	Call deposits		-		4,987
	Restricted cash		90		90
			16,495		18,867
Cash and Cash Equivalents, Currencies	'
	The Company's cash and cash equivalent balance at December 31, 2013 and 2012 is denominated in the following currencies:
		December 31,
		2013		2012
		U.S. Dollars
	US Dollars		11,015		13,933
	Euro		1,936		1,476
	New Israeli Shekels		1,208		1,742
	Chinese RMB		1,101		1,149
	Other currencies		1,235		567
			16,495		18,867

Inventories_Tables

Inventories (Tables)	12 Months Ended
	Dec. 31, 2013
Inventories [Abstract]	'
Inventories	'
		December 31,
		2013		2012
		U.S. Dollars
	Components		11,115		12,313
	Work in process		3,795		6,658
	Finished products (including systems at customer locations not yet sold)		5,226		6,454
			20,136		25,425
	Inventories are presented in:
		December 31,		December 31,
		2013		2012
		U.S. Dollars
	Current assets		17,911		18,335
	Long-term assets (A)		2,225		7,090
			20,136		25,425
	(A)          Long-term Inventory:
	At December 31, 2013, $2,225 of the Company's inventory is classified in long-term assets based on Management's estimate and the recent level of sales (at December 31, 2012- $7,090). Of this amount, $1,353 is comprised of spare parts (at December 31, 2012 - $2,193). The Company's policy is to keep components to provide support and service to systems sold by it to its customers over the past years (usually the support is over a period of seven to ten years) until the Company announces it will not continue to support certain systems. Therefore, this inventory is usually consumed over longer periods than inventory held for sale, and as such the respective amount that is not expected to be consumed in the next year is classified as non-current. Management believes that this amount will be utilized according to its forecasted sales. Management believes no loss will be incurred on its disposition.
	The remaining portion of long-term inventory consists of DMD components and systems which in Management's estimation will not be sold during the next 12 months. Management believes that according to its forecasted sales this amount will mainly be utilized in 2015. Management believes no loss will be incurred on its disposition.

Other_Current_Assets_Tables

Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Other Current Assets [Abstract]	'
Other Current Assets	'
		December 31,		December 31,
		2013		2012
		U.S. Dollars
	Due from Government institutions		424		501
	Prepaid expenses		454		427
	Advances to suppliers		290		340
	Deposits for operating leases		69		151
	Other		676		791
			1,913		2,210

Property_Plant_and_Equipment_N1

Property, Plant and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment, Net [Abstract]	'
Fixed Assets	'
		December 31,
		2013		2012
		U.S. Dollars
	Land		863		863
	Building		10,245		10,230
	Machinery and equipment		6,504		9,721
	Office furniture and equipment		1,202		997
	Computer equipment and software		4,566		5,683
	Automobiles		65		99
	Leasehold improvements		1,048		1,237
			24,493		28,830
	Less accumulated depreciation		10,012		13,008
			14,481		15,822

Other_Assets_Tables

Other Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Other Assets [Abstract]	'
Other Assets	'
		December 31,
		2013		2012
		U.S. Dollars
	Deposits for operating leases		339		304

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets, Net [Abstract]	'
Goodwill	'
		December 31,
		2013			2012
		U.S. Dollars
	Goodwill		3,653			3,653
	Accumulated impairment losses		(2,098	)		(2,074	)
			1,555			1,579
Intangible Assets, Net	'
		December 31,
		2013			2012
		U.S. Dollars
	Patent registration costs		1,805			1,663
	IPR&D		1,002			1,002
	Technology		2,854			2,854
	Customer relationships		45			45
	Intangible assets at cost		5,706			5,564
	Accumulated amortization and impairment		4,698			2,593
	Total intangible asset, net		1,008			2,971
Estimated Amortization Expense	'
	As of December 31, 2013, the estimated amortization expenses of intangible assets for the years 2014 to 2018 is as follows:
	Year ending December 31,	U.S. Dollars
	2014		163
	2015		162
	2016		162
	2017		139
	2018		123
			749

Other_Current_Liabilities_Tabl

Other Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Other Current Liabilities [Abstract]	'
Schedule of Other Current Liabilities	'
		December 31,
		2013			2012
		U.S. Dollars
	Accrued employee compensation and related benefits		6,546			5,478
	Accrued expenses		2,291			2,076
	Commissions		2,040			1,895
	Advances from customers and deferred revenues		1,985			1,843
	Accrued warranty costs		1,304			1,150
	Government institutions		992			864
	Current maturities of contingent consideration (1)		268			335
	Current maturities of OCS liability (1)		159			209
			15,585			13,850
Changes In Product Warranty Obligation	'
	Changes in the accrued warranty costs are as follows:
		Year Ended December 31,
		2013			2012			2011
		U.S. Dollars
	Beginning of year		1,150			1,637			1,494
	New warranties		2,327			2,159			3,179
	Reductions		(2,173	)		(2,646	)		(3,036	)
	Balance at end of year		1,304			1,150			1,637
	(1)           See also Note 14 - Other long-term liabilities

Other_LongTerm_Liabilities_Tab

Other Long-Term Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Other Long-Term Liabilities [Abstract]	'
Other Long-Term Liabilities	'
			December 31,
			2013		2012
			U.S. Dollars
	Liability for contingent consideration in respect of
	business combinations (1)			1,762		4,968
	Liability to OCS, mainly in respect of business combinations (2)			3,996		5,281
				5,758		10,249
		-1	In accordance with ASC Topic 820 (Statement 157), the Company's liabilities for contingent consideration in respect of the acquisitions of Printar and SELA (see Note 23) are measured at fair value using Level 3 inputs. See Note 1B for the effect of the Company's decision regarding SELA's future operations.
		-2	Liability to OCS is in respect of the acquisitions of Printar, SELA and new grants received in 2010 and 2009. See Note 1B for the effect of the Company's decision regarding SELA's future operations.
	The effective interest rate used in the capitalization of the liabilities to the OCS in respect of the acquisitions of Printar and SELA as of December 31, 2013 were 10% and 21%, respectively. (As of December 31, 2012, 16% and 20%, for Printar and SELA, respectively).

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies [Abstract]	'
Minimum Future Rental Payments	'
	As of December 31, 2013, minimum future rental payments under such non-cancelable operating leases are as follows:
	Year Ending	U.S. Dollars
	December 31,
	2014		1,533
	2015		873
	2016		416
	Thereafter		-
			2,822
Allowance for Doubtful Accounts	'
	The following is a summary of the allowance for doubtful accounts related to accounts receivable for the years ended December 31:
		Balance at										Balance at
		beginning				Reversal of			Write-off of			end of
		of period		Provision		provision			provision			period
		U.S. Dollars
	2011		3,854		357		(359	)		(1,625	)		2,227
	2012		2,227		307		(140	)		(1,071	)		1,323
	2013		1,323		272		(218	)		(16	)		1,361

Concentration_of_Risk_and_Fina1

Concentration of Risk and Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2013
Concentration of Risk and Financial Instruments [Abstract]	'
Derivative Instruments	'
		Notional amount		Fair value
		U.S. Dollars
	Options
	Buy put options (Buy dollars and Sell NIS)		200		7
	Sell call options (Sell dollars and Buy NIS)		200		-

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2013
Shareholders' Equity [Abstract]	'
Fair Value Assumptions	'
		2013 Grant			2012 Grant
	Valuation assumptions:
	Dividend yield	0			0
	Expected volatility	64%-69%			63%
	Risk-free interest rate	1.74%			0.84%-0.92%
	Expected life (years)	6.4			6.2-6.4
	Vesting period (years)	4			4
Stock Option Activity	'
	Share option activity during the past three years is as follows:
		Year Ended December 31,
		2013							2012					2011
						Weighted						Weighted					Weighted
		Number				average			Number			average		Number			average
		of				exercise			of			exercise		Of			exercise
		options				price US$			options			price US$		options			price US$
	Outstanding at January 1		1,195,085				3.15			1,234,199			3.31		489,701			3.21
	Granted		75,000				1.73			134,010			1.6		846,804			3.35
	Forfeited and cancelled		(174,915	)			2.96			(173,124	)		3.11		(53,400	)		3.35
	Exercised		(359,651	)			3.26			-			-		(48,906	)		2.98
	Outstanding at year end		735,519				2.99			1,195,085			3.15		1,234,199			3.31
	Vested at year end		368,016				3.42			395,395			3.29		412,395			3.26
									Weighted			Aggregate
		Number				Weighted			Average			intrinsic
		of				average			Remaining			Value (in
		options				exercise			Contractual			US$
		outstanding				price US$			term (years)			thousands)
	Outstanding as of December 31, 2013		735,519				2.99			7.21			813
	Vested and expected to vest at
	December 31, 2013		676,677				2.99			7.21			748
	Exercisable at December 31, 2013		368,016				3.42			6.22			275
Information about Share Options	'
	The following table summarizes information about share options at December 31, 2013:
										Weighted
										average
			Number of							remaining
			outstanding				Number			contractual
	Exercise price US$		options				exercisable			life in years
	0-2			204,190				30,180			9.08
	5-Mar			521,329				327,836			6.56
	7-Jun			10,000				10,000			2.58
				735,519				368,016			7.21
Information about Nonvested Options	'
	The following table summarizes information about nonvested options at December 31, 2013:
						Weighted
						average
						grant- date
		Options				fair value
	Balance at January 1, 2013		799,690				1.8
	Granted		75,000				1.19
	Vested		(420,277	)			2.17
	Forfeited		(86,910	)			1.5
	Balance at December 31, 2013		367,503				1.32
Restricted Share Unit Plan	'
	Activity under the Restricted Share Unit Plan was as follows:
		Awards				Number of			Weighted-
		available				awards			average
		for grant				outstanding			fair value US$
	Balance as of December 31, 2012		665,825				153,246			0.39
	Awards granted		-				-			-
	Exercised		-				(148,942	)		0.39
	Forfeited		4,304				(4,304	)		0.38
	Balance as of December 31, 2013		670,129				-			-

Earnings_Per_Ordinary_Share_Ta

Earnings Per Ordinary Share (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Ordinary Share [Abstract]	'
Computation of Basic and Diluted Earnings (Loss) Per Ordinary Share	'
	The following table summarizes information related to the computation of basic and diluted earnings per Ordinary Share for the years indicated:
		Year Ended December 31,
		2013		2012		2011
		U.S. Dollars (In thousands, except per share data)
	Net income attributable to Ordinary Shares		7		3		5,378
	Weighted average number of Ordinary Shares
	outstanding used in basic earnings per Ordinary
	Share calculation		30,040		29,849		29,557
	Add assumed exercise of outstanding dilutive
	potential Ordinary Shares		54		164		452
	Weighted average number of Ordinary Shares
	Outstanding used in diluted earnings per Ordinary
	Share calculation		30,094		30,013		30,009
	Basic income per Ordinary Share		0		0		0.18
	Diluted income per Ordinary Share		0		0		0.18
	Number of options excluded from the diluted
	earnings per share calculation due to their
	anti-dilutive effect		526		976		1,082

Geographic_Information_Tables

Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2013
Geographic Information [Abstract]	'
Schedule of Revenues by Geographic Area	'
	Revenues are attributable to geographic areas/countries based upon the destination of shipment of products and related services as follows:
		Year Ended December 31,
		2013		2012		2011
		U.S. Dollars
	China and Hong Kong		25,889		25,008		34,113
	Korea		15,691		17,004		23,233
	Asia- Other		6,072		10,739		7,487
	United States		11,705		9,482		11,699
	Taiwan		14,543		11,292		16,458
	Western Europe		6,519		6,998		6,956
	Japan		4,010		2,370		4,618
	Rest of the world		976		1,654		2,464
			85,405		84,547		107,028

Selected_Income_Statement_Data1

Selected Income Statement Data (Tables)	12 Months Ended
	Dec. 31, 2013
Selected Income Statement Data [Abstract]	'
Selected Income Statement Data	'
	A.           Revenues
		Year Ended December 31,
		2013			2012			2011
		U.S. Dollars
	Printed Circuit Boards and
	IC substrates		19,442			16,479			30,708
	Microelectronics		48,422			50,450			57,696
	Service fees		17,541			17,618			18,624
	Total Revenues		85,405			84,547			107,028
	B.           Selling, general and administrative expenses
		Year Ended December 31,
		2013			2012			2011
		U.S. Dollars
	Selling (1)		13,906			13,827			15,614
	General and administrative		8,456			7,311			8,727
			22,362			21,138			24,341
	(1)           Including shipping and handling costs		652			1,076			1,469
	C.           Financial income (expenses), net
		Year Ended December 31,
		2013			2012			2011
		U.S. Dollars
	Interest expense		(181	)		(163	)		(100	)
	Interest income		90			38			32
	Re-evaluation of contingent consideration		(858	)		1,037			(1,264	)
	Interest expense on liabilities to the OCS		(504	)		(667	)		(791	)
	Other, net		(285	)		(12	)		(777	)
			(1,738	)		233			(2,900	)

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]	'
Composition of Income (Loss) Before Income Taxes and Income Tax Expense (Benefit)	'
			Year Ended December 31,
			2013			2012			2011
			U.S. Dollars
	Income (loss) before income taxes:
	Israel			(2,638	)		(1,299	)		677
	Non-Israeli			2,036			1,512			5,445
				(602	)		213			6,122
	Income tax expense (benefit):
	Current:
	Israel			121			44			45
	Non-Israeli			709			398			735
				830			442			780
	Deferred:
	Israel			(1,287	)		-			-
	Non-Israeli			(152	)		(232	)		(36	)
				(1,439	)		(232	)		(36	)
				(609	)		210			744
Reconciliation of The Theoretical Income Tax Expense (Benefit)	'
	The following is a reconciliation of the theoretical income tax expense, assuming all income is taxed at the statutory tax rate applicable to Israeli companies, and the actual income tax expense:
			Year Ended December 31,
			2013			2012			2011
			U.S. Dollars
	Income (loss) before income taxes			(602	)		213			6,122
	Statutory tax rate			25	%		25	%		24	%
	Theoretical income tax expense  (benefit)			(151	)		53			1,469
	Increase (decrease) in income tax expense resulting from:
	Tax expense (benefits) arising from "Approved and
	Beneficiating Enterprises" and preferential tax rate in China			711			492			3,347
	Change in valuation allowance(*)			586			(983	)		(5,423	)
	Non-deductible expenses(**)			218			650			139
	Differences between Israeli currency
	and dollar-adjusted financial statements-net			(1,133	)		160			686
	Purchase price adjustment for contingent liabilities			(580	)		-			-
	Foreign tax rate differential			(101	)		29			(11	)
	Other			( 159	)		(191	)		537
	Actual income tax expense (benefit)			(609	)		210			744
	Per share effect of the tax benefits arising from
	"Approved and Beneficiating Enterprises" and
	preferential tax rate in China:
	Basic		$	0		$	0.02		$	0.11
	Diluted		$	0		$	0.02		$	0.11
		(*)	In 2013 an amount of $1,780 is a decrease in tax expense in respect to a change in the effective tax rate from Beneficiary enterprise and an amount of $338 is an increase in tax expense resulting from losses not available for future years. In addition, Included within the change in valuation allowance are realized benefits of operating loss carryforwards of $68, $635 and $2,007, for the years ended December 31, 2013, 2012 and 2011, respectively.
		(**)	Including non-deductible share based compensation.
Schedule of Deferred Tax Assets and Liabilities	'
	The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are presented below:
			December 31,
			2013			2012
			U.S. Dollars
	Deferred tax assets:
	Allowance for doubtful accounts			96			82
	Accrued warranty			109			26
	Unearned revenue			151			182
	Accrued expenses			303			370
	Net operating losses (NOL) and tax credit carryforwards			4,398			4,258
	Other temporary differences*			663			1,027
	Total gross deferred tax assets			5,720			5,945
	Valuation allowance			(3,609	)		(5,141	)
	Deferred tax asset, net of valuation allowance			2,111			804
	Deferred tax liability:
	Property, plant and equipment			(198	)		(330	)
	Net deferred tax assets			1,913			474
	*          Other temporary differences primarily relate to research and development expenses

Balances_and_Transactions_with1

Balances and Transactions with Related Parties (Tables)	12 Months Ended
	Dec. 31, 2013
Balances and Transactions with Related Parties [Abstract]	'
Schedule of Related Party Balances and Transactions	'
	A.            Balances with related parties:
		December 31,		December 31,
		2013		2012
		U.S. Dollars
	Accounts receivable		43		-
	Accounts payable		6		-
	Due from affiliated companies		233		391
	B.            Transactions with related parties:
		Year Ended December 31,
		2013		2012		2011
		U.S. Dollars
	Purchases from Parent and affiliates		57		-		1,555
	Interest income from Parent		4		15		31
	Sales to Parent and affiliated companies		347		142		2,397

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Measurements [Abstract]	'
Schedule of Recurring Fair Value Measurements	'
	The following table presents the Company's assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and December 31, 2012, aggregated by the level in the fair-value hierarchy within which those measurements fall:
					Quoted Prices in				Significant
					Active Markets for		Significant Other		Unobservable
		December 31,			Identical Assets		Observable Inputs		Inputs
	Description	2013			(Level 1)		(Level 2)		(Level 3)
		U.S. Dollars
	Assets
	Foreign currency derivative contracts		7			-		7		-
	Total Assets		7			-		7		-
	Liabilities
	Contingent consideration		2,030			-		-		2,030
	Total Liabilities		2,030			-		-		2,030
					Quoted Prices in				Significant
					Active Markets		Significant Other		Unobservable
		December 31,			for Identical Assets		Observable Inputs		Inputs
	Description	2012			(Level 1)		(Level 2)		(Level 3)
		U.S. Dollars
	Assets
	Foreign currency derivative contracts		74			-		74		-
	Total Assets		74			-		74		-
	Liabilities
	Contingent consideration		5,303			-		-		5,303
	Total Liabilities		5,303			-		-		5,303
Roll-Forward of The Fair Value of Level 3 Liabilities	'
	The following tables present a roll-forward of the fair value of Level 3 (significant unobservable inputs) liabilities for the year ended December 31, 2013 and 2012:
		Level 3
		U.S. Dollars
		Contingent consideration
	31-Dec-12		5,303
	Settlement of liabilities		(639	)
	Revaluation of fair value included in statement of operations		(2,634	)
	31-Dec-13		2,030
		Level 3
		U.S. Dollars
		Contingent consideration
	31-Dec-11		6,887
	Settlement of liabilities		(547	)
	Revaluation of fair value included in statement of operations		(1,037	)
	31-Dec-12		5,303

Nature_of_Operations_Schedule_

Nature of Operations (Schedule of Details of Impairment) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Impairment [Line Items]	'	'	'
Total	$500,000	'	'
Reorganization and impairment	-3,466,000	3,031,000	'
Cost of Revenues	51,003,000	47,482,000	59,588,000
Inventory write-off [Member]	'	'	'
Impairment [Line Items]	'	'	'
Cost of Revenues	3,100,000	'	'
Impairment charge [Member]	'	'	'
Impairment [Line Items]	'	'	'
Reorganization and impairment	1,700,000	'	'
Revaluation of Liabilities [Member]	'	'	'
Impairment [Line Items]	'	'	'
Reorganization and impairment	-5,100,000	'	'
Other (mainly due to disposal of fixed assets) [Member]	'	'	'
Impairment [Line Items]	'	'	'
Relevant areas in consolidated statement of income	$800,000	'	'

Nature_of_Operations_Narrative

Nature of Operations (Narrative) (Details) (Camtek [Member])	Dec. 31, 2013
Camtek [Member]	'
Schedule of Equity Method Investments [Line Items]	'
Ownership percentage	55.65%

Significant_Accounting_Policie3

Significant Accounting Policies (Annual Rates of Depreciation) (Details)	12 Months Ended
	Dec. 31, 2013
Building [Member]	'
Property, Plant and Equipment [Line Items]	'
Annual rate of depreciation	2.00%
Machinery and Equipment [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Annual rate of depreciation	33.00%
Machinery and Equipment [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Annual rate of depreciation	10.00%
Computer equipment and software [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Annual rate of depreciation	33.00%
Computer equipment and software [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Annual rate of depreciation	20.00%
Office Furniture and Equipment [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Annual rate of depreciation	20.00%
Office Furniture and Equipment [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Annual rate of depreciation	6.00%
Automobiles [Member]	'
Property, Plant and Equipment [Line Items]	'
Annual rate of depreciation	15.00%

Cash_and_Cash_Equivalents_Cash

Cash and Cash Equivalents (Cash and Cash Equivalents) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Cash and Cash Equivalents [Line Items]	'	'
Cash	$16,495	$18,867
Bank balances [Member]	'	'
Cash and Cash Equivalents [Line Items]	'	'
Cash	16,405	13,790
Call deposits [Member]	'	'
Cash and Cash Equivalents [Line Items]	'	'
Cash	'	4,987
Restricted cash [Member]	'	'
Cash and Cash Equivalents [Line Items]	'	'
Cash	$90	$90

Cash_and_Cash_Equivalents_Curr

Cash and Cash Equivalents (Currencies) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Thousands, unless otherwise specified
Cash and Cash Equivalents [Line Items]	'	'	'	'
Cash and cash equivalents	$16,495	$18,867	$22,185	$9,577
U.S. dollars [Member]	'	'	'	'
Cash and Cash Equivalents [Line Items]	'	'	'	'
Cash and cash equivalents	11,015	13,933	'	'
Euro [Member]	'	'	'	'
Cash and Cash Equivalents [Line Items]	'	'	'	'
Cash and cash equivalents	1,936	1,476	'	'
New Israeli Shekels [Member]	'	'	'	'
Cash and Cash Equivalents [Line Items]	'	'	'	'
Cash and cash equivalents	1,208	1,742	'	'
Chinese RMB [Member]	'	'	'	'
Cash and Cash Equivalents [Line Items]	'	'	'	'
Cash and cash equivalents	1,101	1,149	'	'
Other Currencies [Member]	'	'	'	'
Cash and Cash Equivalents [Line Items]	'	'	'	'
Cash and cash equivalents	$1,235	$567	'	'

Inventories_Inventories_Detail

Inventories (Inventories) (Details) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Inventories [Abstract]	'		'
Components	$11,115		$12,313
Work in process	3,795		6,658
Finished products (including systems at customer locations not yet sold)	5,226		6,454
Total inventories	20,136		25,425
Current assets	17,911		18,335
Long term assets	$2,225	[1]	$7,090
[1]	Long-term Inventory: At December 31, 2013, $2,225 of the Company's inventory is classified in long-term assets based on Management's estimate and the recent level of sales (at December 31, 2012- $7,090). Of this amount, $1,353 is comprised of spare parts (at December 31, 2012 - $2,193). The Company's policy is to keep components to provide support and service to systems sold by it to its customers over the past years (usually the support is over a period of seven to ten years) until the Company announces it will not continue to support certain systems. Therefore, this inventory is usually consumed over longer periods than inventory held for sale, and as such the respective amount that is not expected to be consumed in the next year is classified as non-current. Management believes that this amount will be utilized according to its forecasted sales. Management believes no loss will be incurred on its disposition. The remaining portion of long-term inventory consists of DMD components and systems which in Management's estimation will not be sold during the next 12 months. Management believes that according to its forecasted sales this amount will mainly be utilized in 2015. Management believes no loss will be incurred on its disposition.

Inventories_Narrative_Details

Inventories (Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013
In Thousands, unless otherwise specified			Minimum [Member]	Maximum [Member]
Long Term Inventory [Line Items]	'	'	'	'
Inventory, Gross	$2,225	$7,090	'	'
Other Inventories, Spare Parts, Gross	1,353	2,193	'	'
Customer support, term	'	'	'7 years	'10 years
Obsolescence provision	3,052	1,420	'	'
Provision for damages, obsolete, excess and slow-moving inventory	$540	$406	'	'

Other_Current_Assets_Details

Other Current Assets (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Other Current Assets [Abstract]	'	'
Due from Government institutions	$424	$501
Prepaid expenses	454	427
Advances to suppliers	290	340
Deposits for operating leases	69	151
Other	676	791
Other current assets	$1,913	$2,210

Property_Plant_and_Equipment_N2

Property, Plant and Equipment, Net (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross	$24,493	$28,830	'
Less accumulated depreciation	10,012	13,008	'
Fixed assets, net	14,481	15,822	'
Depreciation expenses	2,166	1,640	1,911
Land [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross	863	863	'
Building [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross	10,245	10,230	'
Machinery and Equipment [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross	6,504	9,721	'
Office Furniture and Equipment [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross	1,202	997	'
Computer equipment and software [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross	4,566	5,683	'
Automobiles [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross	65	99	'
Leasehold Improvements [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, Plant and Equipment, Gross	$1,048	$1,237	'

LongTerm_Restricted_Deposit_De

Long-Term Restricted Deposit (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Oct. 31, 2012
In Thousands, unless otherwise specified
Long-Term Restricted Deposit [Abstract]	'	'	'
Appeal bond, amount	$729	$729	$729

Other_Assets_Details

Other Assets (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Other Assets [Abstract]	'	'
Deposits for operating leases	$339	$304

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets, Net (Goodwill) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Goodwill [Line Items]	'	'
Goodwill	$3,653	$3,653
Accumulated impairment losses	-2,098	-2,074
Net goodwill	1,555	1,579
SELA [Member]	'	'
Goodwill [Line Items]	'	'
Impairment loss on goodwill	24	1,499
Printar [Member]	'	'
Goodwill [Line Items]	'	'
Impairment loss on goodwill	'	$575

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets, Net (Intangible Assets, Net) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Goodwill and Intangible Assets, Net [Abstract]	'	'
Patent registration costs	$1,805	$1,663
IPR&D	1,002	1,002
Technology	2,854	2,854
Customer relationships	45	45
Intangible assets at cost	5,706	5,564
Accumulated amortization and impairment	4,698	2,593
Total intangible assets, net	$1,008	$2,971

Goodwill_and_Intangible_Assets4

Goodwill and Intangible Assets, Net (Estimated Amortization Expense) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]	'	'	'
Amortization expense related to intangible assets	$421	$485	$455
Write-off of patents, net value	33	28	24
2014	163	'	'
2015	162	'	'
2016	162	'	'
2017	139	'	'
2018	123	'	'
Total amortization expense	749	'	'
Impairment of intangible assets	$1,684	$957	'
Patent Registration Costs [Member]	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'
Estimated Useful life	'10 years	'	'
IP R&D [Member]	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'
Estimated Useful life	'10 years	'	'

Short_Term_Loan_Details

Short Term Loan (Details) (USD $)	Aug. 31, 2010	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012
In Thousands, unless otherwise specified	Leumi L'Israel [Member]	Mizrahi and Leumi L'Israel [Member]	Mizrahi and Leumi L'Israel [Member]	Mizrahi and Leumi L'Israel [Member]
			Minimum [Member]	Maximum [Member]
Short-term Debt [Line Items]	'	'	'	'
Short-term bank loans, fixed interest rate	'	'	3.00%	3.50%
Short-term loan	$1,400	$4,160	'	'
Short-term Debt, Terms	'	'The loans were each for up to twelve months and accrue interest in the range of Libor + 3%to Libor + 3.5%.	'	'

Other_Current_Liabilities_Othe

Other Current Liabilities (Other Current Liabilities) (Details) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Other Current Liabilities [Abstract]	'		'
Accrued employee compensation and related benefits	$6,546		$5,478
Accrued expenses	2,291		2,076
Commisions	2,040		1,895
Advances from customers and deferred revenues	1,985		1,843
Accrued warranty costs	1,304		1,150
Government institutions	992		864
Current maturities of contingent consideration	268	[1]	335	[1]
Current maturities of OCS liability	159	[1]	209	[1]
Total other current liabilities	$15,585		$13,850
[1]	See also Note 14 - Other long-term liabilities

Other_Current_Liabilities_Chan

Other Current Liabilities (Changes In Product Warranty Obligations) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Other Current Liabilities [Abstract]	'	'	'
Beginning of year	$1,150	$1,637	$1,494
New warranties	2,327	2,159	3,179
Reductions	-2,173	-2,646	-3,036
Balance at end of year	$1,304	$1,150	$1,637

LongTerm_Loans_Narrative_Detai

Long-Term Loans (Narrative) (Details) (USD $)	Aug. 31, 2011	Dec. 31, 2011	Aug. 31, 2010
In Thousands, unless otherwise specified	Mizrahi [Member]	Leumi L'Israel [Member]	Leumi L'Israel [Member]
Short-term Debt [Line Items]	'	'	'
Long-term debt	$2,000	$2,500	$1,300

Liability_for_Employee_Severan1

Liability for Employee Severance Benefits (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Liability for Employee Severance Benefits [Abstract]	'	'	'
Severance liability	$858	$710	'
Severance expenses	$1,081	$1,104	$1,073

Other_LongTerm_Liabilities_Det

Other Long-Term Liabilities (Details) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Other Long Term Liabilities [Line Items]	'		'
Liability for contingent consideration in respect of business combinations	$1,762	[1]	$4,968	[1]
Total other long-term liabilities	5,758		10,249
OCS [Member]	'		'
Other Long Term Liabilities [Line Items]	'		'
Liability for contingent consideration in respect of business combinations	$3,996	[2]	$5,281	[2]
Sela Acquisition [Member] | OCS [Member]	'		'
Other Long Term Liabilities [Line Items]	'		'
Effective interest rate used in the capitalization of the liabilities to the OCS	21.00%		20.00%
Printar [Member] | OCS [Member]	'		'
Other Long Term Liabilities [Line Items]	'		'
Effective interest rate used in the capitalization of the liabilities to the OCS	10.00%		16.00%
[1]	In accordance with ASC Topic 820 (Statement 157), the Company's liabilities for contingent consideration in respect of the acquisitions of Printar and SELA (see Note 23) are measured at fair value using Level 3 inputs. See Note 1B for the effect of the Company's decision regarding SELA's future operations.
[2]	Liability to OCS is in respect of the acquisitions of Printar, SELA and new grants received in 2010 and 2009. See Note 1B for the effect of the Company's decision regarding SELA's future operations. The effective interest rate used in the capitalization of the liabilities to the OCS in respect of the acquisitions of Printar and SELA as of December 31, 2013 were 10% and 21%, respectively. (As of December 31, 2012, 16% and 20%, for Printar and SELA, respectively).

Commitments_and_Contingencies_1

Commitments and Contingencies (Narrative) (Details) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Oct. 31, 2012

Dec. 31, 2013

Dec. 31, 2011

Aug. 31, 2010

Jul. 31, 2011

Dec. 31, 2013

Aug. 31, 2011

Mar. 26, 2012

Aug. 31, 2011

Jan. 31, 2011

Aug. 28, 2009

Mar. 31, 2009

Dec. 31, 2012

Aug. 22, 2011

Mar. 31, 2011

Dec. 31, 2013

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2013

Dec. 31, 2012

Leumi L'Israel [Member]

Leumi L'Israel [Member]

Leumi L'Israel [Member]

Mizrahi [Member]

Mizrahi [Member]

Mizrahi [Member]

Rudolph [Member]

Rudolph [Member]

Rudolph [Member]

Rudolph [Member]

Rudolph [Member]

Rudolph [Member]

Rudolph [Member]

Rudolph [Member]

OCS [Member]

OCS [Member]

OCS [Member]

OCS [Member]

OCS [Member]

OCS [Member]

OCS [Member]

OCS [Member]

OCS [Member]

Unspecified Attorney Fees [Member]

Printar [Member]

Printar [Member]

Printar [Member]

Printar [Member]

Sela Acquisition [Member]

Sela Acquisition [Member]

Commitments And Contingencies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount of claim filed against the company

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,200,000

'

'

'

'

'

'

'

'

'

Litigation awarded value

'

'

'

'

'

'

'

'

'

1,292,000

8,023,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Damages paid, value

'

'

'

'

'

'

'

'

'

'

646,000

646,000

'

6,800,000

'

'

'

'

'

'

'

'

'

'

'

'

Attorney fees

'

'

'

'

'

'

'

'

'

71,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Prejudgment interest paid, amount

'

'

'

'

'

'

'

'

'

'

'

'

1,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Possible range of loss, minimum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Possible range of loss, maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

650,000

8,200,000

'

'

'

'

'

'

'

'

'

'

Long-term debt

'

'

'

'

2,500,000

1,300,000

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Short-term loan

'

'

'

'

'

1,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Appeal bond, amount

729,000

729,000

729,000

'

'

'

'

5,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Factoring facilities

'

'

'

'

'

1,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank guarantee

'

'

'

'

'

8,925,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank covenant agreement, required adjusted shareholders equity, minimum amount

'

'

'

'

40,000,000

'

40,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank covenant agreement, maximum percent of debt to open receivables ratio

'

'

'

70.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank covenant agreement, ratio of customers balances and cash balances, minimum percent required

'

'

'

'

'

'

150.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank covenant agreement, ratio of company's credit facilities, maximum percent

'

'

'

'

'

'

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank covenant agreement, minimum percent of total balance sheet

'

'

'

50.00%

'

'

40.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank covenant agreement, required annual sales, minimum amount

'

'

'

'

60,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Bank covenant agreement, required cash, minimum amount

'

'

'

'

11,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percent of sales derived from research and development, committed amount payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.50%

'

'

'

'

'

'

'

'

Grants received including interest accrued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,810,000

5,660,000

598,000

598,000

2,525,000

2,590,000

Liabilities recorded at fair value

2,030,000

5,303,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,303,000

2,989,000

'

'

202,000

1,903,000

Outstanding purchase commitments for inventory components

6,085,000

7,938,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accrued interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$650,000

$650,000

'

'

'

'

'

'

Commitments_and_Contingencies_2

Commitments and Contingencies (Minimum Future Rental Payments) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Commitments and Contingencies [Abstract]	'	'	'
2014	$1,533	'	'
2015	873	'	'
2016	416	'	'
Thereafter	'	'	'
Total	2,822	'	'
Aggregate office rent expenses	$1,002	$979	$968

Commitments_and_Contingencies_3

Commitments and Contingencies (Allowance For Doubtful Debts) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Commitments and Contingencies [Abstract]	'	'	'
Balance at beginning of period	$1,323	$2,227	$3,854
Provision	272	307	357
Reversal of provision	-218	-140	-359
Write-off of provision	-16	-1,071	-1,625
Balance at end of period	$1,361	$1,323	$2,227

Concentration_of_Risk_and_Fina2

Concentration of Risk and Financial Instruments (Options) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Derivatives, Fair Value [Line Items]	'	'
Gain from derivatives not designated as hedging instruments	'	$608
Loss from derivatives not designated as hedging instruments	-66	'
Foreign Exchange Buy Put Option [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative, Notional Amount	200	'
Derivative, Fair Value, Net	7	'
Foreign Exchange Sell Call Options [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Derivative, Notional Amount	200	'
Derivative, Fair Value, Net	'	'

Shareholders_Equity_Narrative_

Shareholders' Equity (Narrative) (Details) (USD $)

12 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

In Thousands, except Share data, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2002

Sep. 30, 2001

Dec. 31, 2008

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2009

Aug. 31, 2007

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Treasury stock [Member]

Treasury stock [Member]

Treasury stock [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Stock Compensation Plan [Member]

Stock Compensation Plan [Member]

Stock Compensation Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Repurchase Program, Authorized Amount

'

'

'

'

$3,000

$2,000

'

'

'

'

'

'

'

'

Treasury Stock, Shares, Retired

'

'

'

761,619

250,000

1,080,757

'

'

'

'

'

'

'

'

Treasury Stock, Retired, Cost Method, Amount

'

'

'

401

592

905

'

'

'

'

'

'

'

'

Shares available for grant

1,598,800

'

'

'

'

'

670,129

665,825

'

1,500,000

300,000

'

'

'

Vesting period (years)

'4 years

'4 years

'

'

'

'

'4 years

'

'

'

'

'

'

'

Stock option terms, years

'10 years

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional options available for grant

207,956

'

'

'

'

'

'

'

'

1,200,000

'

'

'

'

Granted

75,000

134,010

846,804

'

'

'

'

'

'

'

'

'

'

'

Unrecognized share-based compensation expense

450

'

'

'

'

'

'

'

'

'

'

'

'

'

Share based compensation expense

380

401

417

'

'

'

19

72

120

'

'

361

329

297

Unrecognized compensation cost, recognition period

'1 year 10 months 24 days

'

'

'

'

'

'

'

'

'

'

'

'

'

The intrinsic value of options exercised

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate intrinsic Value, Outstanding, Vested and expected to vest

$54

'

'

'

'

'

'

'

'

'

'

'

'

'

Shareholders_Equity_Fair_Value

Shareholders' Equity (Fair Value Assumptions) (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Dividend yield	0.00%	0.00%
Expected volatility	'	63.00%
Expected volatility, minimum	64.00%	'
Expected volatility, maximum	69.00%	'
Risk free interest rate	1.74%	'
Risk-free interest rate, minimum	'	0.84%
Risk-free interest rate, maximum	'	0.92%
Expected life (years)	'6 years 4 months 24 days	'
Vesting period (years)	'4 years	'4 years
Minimum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected life (years)	'	'6 years 2 months 12 days
Maximum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected life (years)	'	'6 years 4 months 24 days

Shareholders_Equity_Share_Opti

Shareholders' Equity (Share Option Activity) (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Shareholders' Equity [Abstract]	'	'	'
Outstanding, beginning balance	1,195,085	1,234,199	489,701
Granted	75,000	134,010	846,804
Forfeited and cancelled	-174,915	-173,124	-53,400
Exercised	-359,651	'	-48,906
Outstanding, ending balance	735,519	1,195,085	1,234,199
Vested at year end	368,016	395,395	412,395
Vested and expected to vest at December 31, 2013	676,677	'	'
Exercisable at December 31, 2013	368,016	'	'
Weighted average exercise price, Outstanding, beginning balance	$3.15	$3.31	$3.21
Weighted average exercise price, Granted	$1.73	$1.60	$3.35
Weighted average exercise price, Forfeited and cancelled	$2.96	$3.11	$3.35
Weighted average exercise price, Exercised	$3.26	'	$2.98
Weighted average exercise price, Outstanding, ending balance	$2.99	$3.15	$3.31
Weighted exercise price, Vested at year end	$3.42	$3.29	$3.26
Weighted average exercise price	$2.99	'	'
Weighted average exercise price, Vested and expected to vest at December 31, 2013	$2.99	'	'
Weighted average exercise price, Exercisable at December 31, 2013	$3.42	'	'
Weighted average Remaining Contractual term (years), Outstanding	'7 years 2 months 16 days	'	'
Weighted average Remaining Contractual term (years), Vested and expected to vest	'7 years 2 months 16 days	'	'
Weighted average Remaining Contractual term (years), Exercisable	'6 years 2 months 19 days	'	'
Aggregate intrinsic Value, Outstanding	$813	'	'
Aggregate intrinsic Value, Outstanding, Vested and expected to vest	748	'	'
Aggregate intrinsic Value, Exercisable	$275	'	'

Shareholders_Equity_Informatio

Shareholders' Equity (Information About Share Options) (Details)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	735,519
Weighted average remaining contractual life in years	'7 years 2 months 16 days
Number exercisable	368,016
Exercise price 0-2 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	204,190
Weighted average remaining contractual life in years	'9 years 29 days
Number exercisable	30,180
Exercise price 3-5 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	521,329
Weighted average remaining contractual life in years	'6 years 6 months 22 days
Number exercisable	327,836
Exercise price 6-7 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	10,000
Weighted average remaining contractual life in years	'2 years 6 months 29 days
Number exercisable	10,000

Shareholders_Equity_Informatio1

Shareholders' Equity (Information About Nonvested Options) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Shareholders' Equity [Abstract]	'
Options, beginning balance	799,690
Options, Granted	75,000
Options, Vested	-420,277
Options, Forfeited	-86,910
Options, ending balance	367,503
Weighted average fair value, beginning balance	$1.80
Weighted average grant- date fair value, Granted	$1.19
Weighted average grant- date fair value, Vested	$2.17
Weighted average grant- date fair value, Forfeited	$1.50
Weighted average fair value, ending balance	$1.32

Shareholders_Equity_Restricted

Shareholders' Equity (Restricted Share Unit Plan) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2009	Aug. 31, 2007
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Awards available for grant, ending balance	1,598,800	'	'
Weighted average fair value, beginning balance	$1.80	'	'
Weighted average fair value, Awards granted	$1.19	'	'
Weighted average fair value, Forfeited	$1.50	'	'
Weighted average fair value, ending balance	$1.32	'	'
Restricted Stock Units (RSUs) [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Awards available for grant, beginning balance	665,825	1,500,000	300,000
Awards available for grant, awards granted	'	'	'
Awards available for grant, exercised	'	'	'
Awards available for grant, forfeited	4,303	'	'
Awards available for grant, ending balance	670,129	1,500,000	300,000
Number of awards outstanding, beginning balance	153,246	'	'
Number of awards outstanding, Awards granted	'	'	'
Number of awards outstanding, Exercised	-148,942	'	'
Number of awards outstanding, Forfeited	-4,304	'	'
Number of awards outstanding, ending balance	'	'	'
Weighted average fair value, beginning balance	$0.39	'	'
Weighted average fair value, Awards granted	'	'	'
Weighted average fair value, Exercised	$0.39	'	'
Weighted average fair value, Forfeited	$0.38	'	'
Weighted average fair value, ending balance	'	'	'

Earnings_Per_Ordinary_Share_De

Earnings Per Ordinary Share (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Earnings Per Ordinary Share [Abstract]	'	'	'
Net income attributable to Ordinary Shares	$7	$3	$5,378
Weighted average number of Ordinary Shares outstanding used in basic earnings per Ordinary Share calculation	30,040,000	29,849,000	29,557,000
Add assumed exercise of outstanding dilutive potential Ordinary Shares	54,000	164,000	452,000
Weighted average number of Ordinary Shares outstanding used in diluted earnings per Ordinary Share calculation	30,094,000	30,013,000	30,009,000
Basic income per Ordinary Share	$0	$0	$0.18
Diluted income per Ordinary Share	$0	$0	$0.18
Number of options excluded from the diluted earnings per share calculation due to their anti-dilutive effect	526	976	1,082

Geographic_Information_Details

Geographic Information (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	$85,405	$84,547	$107,028
China and Hong Kong [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	25,889	25,008	34,113
Korea [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	15,691	17,004	23,233
Asia-Other [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	6,072	10,739	7,487
United States [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	11,705	9,482	11,699
Taiwan [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	14,543	11,292	16,458
Western Europe [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	6,519	6,998	6,956
Japan [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	4,010	2,370	4,618
Rest of the world [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Revenues	$976	$1,654	$2,464

Selected_Income_Statement_Data2

Selected Income Statement Data (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Selected Income Statement Data [Line Items]	'		'		'
Revenues	$85,405		$84,547		$107,028
Selling	13,906	[1]	13,827	[1]	15,614
General and administrative	8,456		7,311		8,727
Total selling, general and administrative expenses	22,362		21,138		24,341
Shipping and handling costs	652		1,076		1,469
Interest expense	-181		-163		-100
Interest income	90		38		32
Re-evaluation of contingent consideration	-858		1,037		-1,264
Interest expense on liabilities to the OCS	-504		-667		-791
Other, net	-285		-12		-777
Financial income (expenses), net	-1,738		233		-2,900
Foreign currency income (expense), transactions not denominated in U.S. Dollars	-188		84		-308
Printed Circuit Boards and IC Substrates [Member]	'		'		'
Selected Income Statement Data [Line Items]	'		'		'
Revenues	19,442		16,479		30,708
Microelectronics [Member]	'		'		'
Selected Income Statement Data [Line Items]	'		'		'
Revenues	48,422		50,450		57,696
Service fees [Member]	'		'		'
Selected Income Statement Data [Line Items]	'		'		'
Revenues	$17,541		$17,618		$18,624
[1]	Including shipping and handling costs

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Operating Loss Carryforwards [Line Items]	'	'	'
Net change in total valuation allowance	$586	($983)	($5,423)
Major foreign subsidiaries NOL	3,632	'	'
The Company and its subsidiaries in Israel NOL carryforwards, aggregate amount	65,069	'	'
Deferred tax assets relating to net operating losses and other carryforwards, not subject to expiration	1,440	'	'
Deferred tax assets relating to net operating losses and other carryforwards, subject to expiration	2,192	'	'
Effective income tax rate	25.00%	25.00%	24.00%
Undistributed earnings of foreign subsidiaries	14,362	'	'
Minimum [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Expiration of net operating loss carryforwards	31-Dec-13	'	'
Maximum [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Expiration of net operating loss carryforwards	31-Dec-28	'	'
Approved Enterprise[Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Tax-exempt earnings	20,600	'	'
Contingent income tax liabilities, Dividend distribution	5,200,000	'	'
Beneficiating Enterprise [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Tax-exempt earnings	9,400	'	'
Contingent income tax liabilities, Dividend distribution	2,300,000	'	'
The Company [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Net change in total valuation allowance	-1,532	'	'
Affiliates [Member]	'	'	'
Operating Loss Carryforwards [Line Items]	'	'	'
Net change in total valuation allowance	($1,344)	'	'

Income_Taxes_Composition_of_In

Income Taxes (Composition of Income (Loss) Before Income Taxes and Income Tax Expense (Benefit)) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Taxes [Abstract]	'	'	'
Income (loss) before income taxes: Israel	($2,638)	($1,299)	$677
Income (loss) before income taxes: Non-Israeli	2,036	1,512	5,445
Income (loss) before income taxes	-602	213	6,122
Income tax expense (benefit), Current: Israel	121	44	45
Income tax expense (benefit), Current: Non-Israeli	709	398	735
Current Income Tax Expense (Benefit), Total	830	442	780
Deferred: Israel	-1,287	'	'
Deferred: Non-Israeli	-152	-232	-36
Deferred Income Tax Expense, Total	-1,439	-232	-36
Actual income tax expense (benefit)	($609)	$210	$744

Income_Taxes_Income_Taxes_Incl

Income Taxes (Income Taxes Included in The Statement of Operations) (Details) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Income Taxes [Abstract]	'		'		'
Income (loss) before income taxes	($602)		$213		$6,122
Statutory tax rate	25.00%		25.00%		24.00%
Theoretical income tax expense (benefit)	-151		53		1,469
Tax expense (benefits) arising from ''Approved and Beneficiating Enterprises'' and preferential tax rate in China	711		492		3,347
Change in valuation allowance	586	[1],[2]	-983	[1]	-5,423	[1]
Non-deductible expenses	218	[3]	650	[3]	139	[3]
Differences between Israeli currency and dollar-adjusted financial statements-net	-1,133		160		686
Purchase price adjustment for contingent liabilities	-580		'		'
Foreign tax rate differential	-101		29		-11
Other	-159		-191		537
Actual income tax expense (benefit)	-609		210		744
Per share effect of the tax benefits arising from ''Approved and Beneficiating Enterprises'' and preferential tax rate in China: Basic	$0		$0.02		$0.11
Per share effect of the tax benefits arising from ''Approved and Beneficiating Enterprises'' and preferential tax rate in China: Diluted	$0		$0.02		$0.11
Decrease in tax expense in respect to a change in the effective tax rate from Beneficiary enterprise	1,780		'		'
Increase in tax expense resulting from losses not available for future years	338		'		'
Net operating loss carry forwards	$68		$635		$2,007
[1]	In 2013 an amount of $1,780 is a decrease in tax expense in respect to a change in the effective tax rate from Beneficiary enterprise and an amount of $338 is an increase in tax expense resulting from losses not available for future years. In addition, Included within the change in valuation allowance are realized benefits of operating loss carryforwards of $68, $635 and $2,007, for the years ended December 31, 2013, 2012 and 2011, respectively.
[2]
[3]	Including non-deductible share based compensation

Income_Taxes_Income_Taxes_Incl1

Income Taxes (Income Taxes Included in The Balance Sheet) (Details) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Deferred tax assets:	'		'
Allowance for doubtful accounts	$96		$82
Accrued warranty	109		26
Unearned revenue	151		182
Accrued expenses	303		370
Net operating losses (NOL) and tax credit carryforwards	4,398		4,258
Other temporary differences	663	[1]	1,027	[1]
Total gross deferred tax assets	5,720		5,945
Valuation allowance	-3,609		-5,141
Deferred tax asset, net of valuation allowance	2,111		804
Deferred tax liability:	'		'
Property, plant and equipment	-198		-330
Net deferred tax assets	$1,913		$474
[1]	Other temporary differences primarily relate to research and development expenses

Balances_and_Transactions_with2

Balances and Transactions with Related Parties (Details) (Affiliated Entity [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Affiliated Entity [Member]	'	'	'
Related Party Transaction [Line Items]	'	'	'
Accounts receivable	$43	'	'
Accounts payable	6	'	'
Due from affiliated companies	233	391	'
Purchases from Parent and affiliates	57	'	1,555
Interest income from Parent	4	15	31
Sales to Parent and affiliated companies	$347	$142	$2,397
Interest rate on unpaid balances between Parent and its subsidiaries	5.50%	5.50%	5.50%

Fair_Value_Measurements_Assets

Fair Value Measurements (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Foreign currency derivative contracts	$7	$74
Total Assets	7	74
Contingent Consideration	2,030	5,303
Total Liabilities	2,030	5,303
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Foreign currency derivative contracts	'	'
Total Assets	'	'
Contingent Consideration	'	'
Total Liabilities	'	'
Significant Other Observable Inputs (Level 2) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Foreign currency derivative contracts	7	74
Total Assets	7	74
Contingent Consideration	'	'
Total Liabilities	'	'
Significant Unobservable Inputs (Level 3) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Foreign currency derivative contracts	'	'
Total Assets	'	'
Contingent Consideration	2,030	5,303
Total Liabilities	$2,030	$5,303

Fair_Value_Measurements_RollFo

Fair Value Measurements (Roll-Forward of The Fair Value of Level 3 Liabilities) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Level 3 Liabilities, Beginning Balance	$5,303	$6,887
Settlement of liabilities	-639	-547
Revaluation of fair value included in statement of operations	-2,634	-1,037
Level 3 Liabilities, Ending Balance	2,030	5,303
Printar [Member]	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Weighted average cost of capital, percent	28.00%	'
Contingent consideration	2,000	'
Total purchase consideration	$2,500	'
Sela Acquisition [Member]	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Weighted average cost of capital, percent	21.00%	'